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Separate renal kallikrein excretions in two-kidney one-clip Goldblatt
hypertensive rats. J.-L. Ader, J.-P. Girolami, T. Tran Van, F. Prad-
daude, J.-P. Eche, and J.-M. Suc. Laboratoire de Physiologie et
Institut National de la Sante et de Ia Recherche Medicale (U 133),
Faculté de Médecine, Toulouse, France. Bilateral renal functions and
kallikrein excretions were measured through separate urine collections
from anesthetized Wistar rats either 1 week (GH 1 rats, N = 8) or 4
weeks (GH 4 rats, N = 8) after placing a silver clip (0.25 mm) on the left
renal artery. GH rats were compared to sham-operated control rats (SO
I rats, N = 4 and SO 4 rats, N = 4). Kallikrein activity was measured by
radioimmunoassay of generated kinins (BK) and was expressed for a
30-mm urine collection. In GH 1 and in OH 4 rats, mean BP (151 18
and 181.1 20.8 mm Hg) and PRA (44.8 18 and 22.5 7.2 ng/ml/hr)
were significantly higher than those of the respective controls. Clipped
kidney urinary kallikrein activity, sodium excretion, GFR, and plasma
flow were lower than those of the controlateral nonclipped kidney (see
table).
Kall. Act.
ng BK
UNaV
smoles/min
GFR
ui/mm
RPF
ui/mm
OH I rats
Left clipped K 114.7 63.3
P < 0.05
0.14 0.10
P < 0.01
536 24
P < 0.01
1247 59
P < 0.01
Right K 220.9 87.8 0.29 0.15 1446 210 3637 531
OH 4 rats
Left clipped K 151.6 94.9
P < 0.01
0.08 0.04
P < 0.01
507 236
P < 0.05
1065 529
P < 0.05
Right K 425 125 2.87 0.9 1033 497 2166 867
OH I rats (left kidney + right kidney) had lower kallikrein excretion
(335.6 138 versus 476.2 140.6 ng BK, P < 0.05) and sodium
excretion (0.43 0.25 versus 0.69 0.30 umoles/min, P < 0.01) than
the 50 1 control rats. GH 4 rats had lower kallikrein excretion (576
179 versus 1078.4 191 ng BK, P < 0.01) and higher sodium excretion
(2.95 I versus 0.39 0.20 umoles/min, P < 0.01) than the SO 4
control rats. In 1 and 4 weeks two-kidney one-clip Goldblatt hyperten-
sion decreased total urinary kininogenase activity was due to the
reduction of the clipped kidney kallikrein excretion. Reduced activity of
the renal kallikrein-kallidin system could be one of the mechanisms of
increased blood pressure.
Mesangial IgA nephropathy: Risk factors. J. BallarIn, A. CovarsI, P.
Barceló, C. Gelpi, J. L. Rodriguez, J. M. Santaularia, and G. Del RIo.
Fundación Puigvert UniversidadAutónoma Barcelona, and Servicio de
Inmunologla, Hospital San Pablo, Barcelona, Spain. The risk factors
in 70 patients with mesangial IgA nephropathy were studied. The
presenting features were gross hematuna (75.4%), urinalysis abnormali-
ties (17.3%), nephrotic syndrome (4.3%), and episodes similar to acute
glomerulonephritis (3%). At the time of renal biopsy 10% of the patients
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exhibited a decreased filtration rate (three of them with short-term
remission) and 13% were hypertensive. Urinalysis was always abnor-
mal: proteinuria and microscopic hematuria (35.7%), isolated protein-
uria (17%), and nephrotic syndrome (4.3%). Light microscopy showed
focal and segmental lesions (45.7%), mild mesangial proliferation in-
volving all glomeruli (32%), minimal change lesions (21.4%), fuchsino-
philic "fibrinoid" deposits in the mesangium (9%), glomerular sclerosis
(7.1%), arteriosclerosis (15.6%), and interstitial abnormalities (17%).
During the follow-up (64 37 months) 12 patients exhibited hyperten-
sion and 24 presented only microscopic heinaturia without proteinuria.
After 10 and 16 years follow-up 48 and 54% had developed chronic renal
failure; 8 and 12% showed signs of endstage renal failure. The patients
with renal failure presented a higher incidence of hypertension (35.4%
vs. 10.2%), glomerular sclerosis (45.4% vs. 17.1%), arteriosclerosis
(54.5% vs. 7%), and interstitial abnormalities (45.4% vs. 12.8%). None
of the 24 patients without proteinuria developed renal failure. Present-
ing features, pathological lesions, serum IgA levels, and complement
component protein levels were not risk factors.
Acetohydroxamic acid in the treatment of ureogenic lithiasis. P.
Barceló, A. Rousaud, and F. Dalet. Fundación Puigvert, Universidad
Autónoma de Barcelona, Barcelona, Spain. Microbian urease is the
main factor that provokes the formation of struvite calculi: magnesium-
ammonia-phosphate (MAP) and carboxi-apatite (CA). Acetohydroxa-
mic acid (AHA) blocks urease and is useful in the therapy of recurrent
ureogenic lithiasis. Fifty-five patients (41 with calculi and 14 without)
with AHA were treated. The doses prescribed ranged from 375 to 750
mg/24 hr. In each patient the following parameters were evaluated: (1)
evolution of the lithiasis, (2) urinary ammonia, (3) MAP and CA in
urine, (4) urine culture, (5) hemostasis test and hemolysis factors, (6)
renal function, and (7) hepatic function. After 6 months, out of the 41
patients with calculi, 28 (69%) were not modified, the calculus increased
in 5 (14%), and in 8 (17%) the x-ray test showed some recovery. In 2
patients (14%) without calculi, there was a recurrence when therapy
was stopped. At the beginning of and during treatment, MAP and/or CA
disappeared (91 to 95%) in both groups and ammonia decreased to
normal values. During treatment, hepatic and renal toxicity were not
found: urinary infection was confirmed in 21 patients after 6 months (16
with calculi and 5 without) versus 36 at the beginning. One patient had
thrombophlebitis and another had hemolytic anemia. AHA avoids the
progression of ureogenic lithiasis in 86% of the patients at short term.
Its toxicity is low at doses less than 750 mg/24 hr. AHA, without
intrinsic antimicrobian effect, provides progressive, stable, and irre-
versible inhibition of urease.
Removal of various metabolites in patients with chronic renal failure on
hemodialysis: Role of red blood cells in the retention of amino acids. G.
Baverel, C. Michoudet, J. F. Moskovtchenko, M. Pellet, and J.
Traeger. Service d'Exploration Fonctionnelle Rénale et Clinique de
Nephrologie et Maladies Metaboliques, Hôpital E. Herriot, Lyon,
France. Whole blood and plasma concentrations of urea, glucose,
lactate, glutamine (OLN), glutamate (GLU), and alanine (ALA) were
measured by enzymatic methods at the 30th and 240th mm of a dialysis
session at the entry and the exit of capillary dialyzer with cellulose
acetate membrane in four patients with chronic renal failure hemodia-
lyzed 3 x 4 hr/week. The percent removal (X 5EM) of these
metabolites from plasma (P) and red blood cells (RBC) was:
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Time
mm P
Urea
RBC
Glucos
P
e
RBC
Lactate
P RBC
30 79.8 78.3 59.3 53.1 54.5 59.3
18.5
240 75.4 74.6 56.9 55.4 58.6 52.4
GLN GLU ALA
Time
mm P RBC P RBC P RBC
30 63.6 7.0 36.6 0 74.8 3.8
240 69.2 8.4 44.0 0 61.2 17.7
These results show that the percent removal of urea, glucose, and
lactate is similar in plasma and red blood cells; by contrast, the amino
acids studied are cleared from the plasma but not from the red blood
cells. It is concluded that, during hemodialysis: (1) Removal of urea,
glucose, and lactate is underestimated when measured only in plasma or
serum. (2) Red blood cells limit the loss of amino acids and probably
also muscular proteolysis.
Plasma and muscular levels of carnitine in T.E.P. G. Bellinghieri, V.
Savica, C. Di Stefano, P. Princi, and F. Consolo. Istituto pluridisciplmn-
are di C/mica Medica e Terapia Medica Generale e Speciale, Univer-
sitd di Messina, Messina, Italy. The importance of adequate muscle
carnitine content for proper cellular lipid metabolism has been known
for a long time. In 1978 BOhmer demonstrated that intermittent hemodi-
alysis causes a heavy loss of camitine from the muscle. BOhmer did not
find a correlation between plasma and muscle carnitine levels, probably
because he did not measure free and acetyl carnitine separately.
Conversely, our results obtained while studying 14 patients on long-
term dialysis found a significant correlation between plasma and muscle
free-carnitine concentrations measured separately in hemodialysis pa-
tients. The results obtained confirm that hemodialytic treatment causes
a dramatic reduction of plasma and muscle carnitine levels. After L-
carnitine treatment, the blood and muscle levels of the metabolite were
found to be increased. Thus, the results of the present study offer an
alternative method for monitoring carnitine levels which may avoid the
use of muscle biopsy.
Tonsillar plasma-cell dysregulation in Berger disease. M. C. Bene, G.
Faure, B. de Ligny, M. Kessler, and J. Duheille. Laboratoire d'Immu-
nologie, Faculté de Médecine, and Clinique Nephrologique, CHU de
Nancy, Vandoeuvre-les-Nancy, France. Berger disease is character-
ized by the presence of mesangial deposits of IgA containing immune
complexes. This suggests that they may be induced in the mucosal
lymphoid tissue and prompt a search for dysregulation at this level.
Since tonsillectomy has been proposed as a treatment in these affec-
tions, we performed an immunohistomorphometrical study of the
plasma-cell population in 20 palatine tonsils obtained from seven
patients and seven control subjects. lgG, IgA, or 1gM secreting cells
were enumerated on frozen-cut serial sections after staining with
monospecific anti-heavy chain immune sera. Results are expressed as
numbers of plasma cells secreting each Ig class per surface unit in
extrafollicular areas. For each tonsil, the percentages of plasma cells for
each Ig class were also calculated. In controls, our results are consist-
ent with those reported in the literature: IgG 64.7%, IgA 28.7%, and
1gM 6.6%, IgA/IgG 0.48. In all patients, we observed a significant
increase of the IgA secreting population: IgG 36.9%, IgA 55.8%, 1gM
7.3%, IgA/IgG 1.51. These results support the hypothesis of a mucosal
origin for the mesangial IgA in Berger disease and bring a theoretical
justification for tonsillectomy in this nephropathy.
Renal amyloidosis. Study of 118 patients. H. Ben MaIz, A. Kheder, F.
Kouki, K. Ayed, A. El Main, and H. Ben Ayed. Service de Médecine
Interne et de Nephrologie, Hôpital Charles Nicolle Tunis, Tunisia.
Renal amyloidosis is frequent in our country. It represents 12.1% of
glomerular nephropathies. One hundred and eighteen patients with
renal amyloidosis, over a period of 6.5 years, were reviewed. The
subjects were 83 males and 35 females. The mean age was 39.6 16.5
years (age range, 7 to 77 years). The amyloidosis was secondary in 106
patients (tuberculosis in 43 patients, bronchopneumopathy in 23 pa-
tients, chronic infection in 24 patients, familial Mediterranean fever in 9
patients, and miscellaneous in 7 patients). Permanent proteinuria was
found in all patients. Table I shows biochemical findings. Renal
insufficiency (serum creatinine 20 mg/liter) was found in 40 patients.
An increase in kidney size was present even when renal function was
impaired (Table 2). Hypotension was found in most of the patients.
Mean systolic blood pressure was 114.6 25.1 mm Hg (100 to 210mm
Hg) and mean diastolic blood pressure was 68.8 16.3 mm Hg (30 to
130 mm Hg). Orthostatic hypotension concerned both systolic (t = 8.48,
— P < 0.001) and diastolic blood pressure (t = 4.5, — P < 0.001).
Hypertension was found in only seven patients. The principal physical
findings except renal symptoms, were: hippocratic finger (27 patients),
hepatomegaly (26 patients), cubital nerve thickening (25 patients), and
macroglossia (20 patients). Thromboembolic complications occurred in
ten patients (venous thrombosis in 4 patients, arterial thrombosis in 4
patients, and arteriovenous shunt thrombosis in 2 patients). The study
of coagulation with determination of antithrombin III levels showed a
kinetic and dynamic hypercoagulability.
Table I Findings Mean (± SD) Range
Proteinuria, g/24 hr
Protidemia, g/liter
Serum albumin, glliter
Lipidimia, glliter
Serum cholesterol, g/liter
5.91 3.48 ito 16
46.16 8.81 28 to 75
14.14 6.53 4.6 to 37.5
10.45 3.75 4.5 to 26
3.25 1.18 1.25 to 7
Table 2 No. of
Serum creatinine patients
Mean of size of kidney
(±sD), cm P
l5 mg/liter 49
15—45 mg/liter 24
>45 mg/liter 8
13.42 1.63 NS
12.73 1.33 NS
12.94 0.82 NS
Enzymuria in the evaluation of cisplatin nephrotoxicity. R. Beretta, E.
Damiani, M. T. Cattaneo, S. Lucchini, G. Grasselli, and T. Tagno-
chetti. C/mica Medica Generale, e C/mica Ostetnica e Ginecologica V,
Ospedale "L. Sacco", Mi/ano, Italy. The value of urinary N-acetyl-
glucosaminidase (NAG) in predicting nephrotoxicity is controversial.
Changes in urinary levels of NAG, measured by a fluorimetric assay,
were studied in nine patients before and after (24 hr) therapy with
dichlorodiammine-cis-platinum (DDP). Five men with cancer of the
lung received cisplatin (80 mg/mEq) as a single agent, and four women
with ovarian cancer received a combination of cisplatin (50 mg/mEq)
and an alkylating drug. A marked increase in enzyme excretion was
observed after the administration of DDP in 19 out of 20 courses (P <
0.00 1). Clinical signs of nephrotoxicity were severe after two courses (1
oliguric ARF and 1 nephrotic syndrome) and moderate after two other
courses (increase in serum creatinine of 0.7 and 1.5 mg%ml.). In the
"toxic" courses the increased percentage in urinary NAG after 24 hr is
significantly (P < 0.001) greater (213 80 nM/hr/mg) than in "nontox-
ic" courses (75 65 nM/hr/mg) despite the variability of results. On the
contrary urinary levels of NAG before treatment are not useful in
predicting drug nephrotoxicity.
Functional modifications of unilateral hypertensive kidney disease. C.
Bianchi, M. Bonadio, C. Donadio, and G. Tramonti. C/mica Medica
Generale 2, Centro Studi Nefrologici "Clara Monasterio Gentili,"
University of Pisa, Pisa, Italy. In 46 hypertensive patients, 22 with
renovascular hypertension (RVH), 15 with unilateral pyelonephritis
(PN), and 9 with essential hypertension (EH), urea clearance, glomeru-
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lar filtration rate (GFR), effective renal plasma flow (ERPF) and, from
their ratio, filtration fraction (FF) of each kidney were measured. For
these determinations the standard technique of ureteral catheterization
was used. In patients with RVH urea clearance of the ischemic kidney
decreased proportionally more than GFR, and both urea clearance and
GFR showed a proportionally greater decrease than ERPF. As a
consequence, the ratios urea clearance/GFR, urea clearance/ERPF,
and FF of the ischemic kidney were lower than those of the contralater-
al one. On the contrary, in patients with PN and with EH the decreases
of the three examined parameters are proportional to one another
without any differences in their ratios.
RVH PN EH
Urea clearancelGFR
Affected 49.21 16.76 57.71 8.93 60.32 5.91
Contralateral 67.62 19.58 56.77 7.99 57.57 6.02
Affected/contralateral 0.77 0.22a 1.02 0.07 1.06 0.16
Urea clearance/ERPF
Affected 11.89 4.18 15.08 4.54 14.18 1.94
Contralateral 17.54 4.67 14.77 4.42 13.80 2.84
Affected/contralateral 0.69 0.18a 1.02 0.07 1.05 0.14
FF
Affected 23.12 3.86 26.48 3.34 23.37 2.86
Contralateral 26.73 3.21 26.34 3.17 23.60 2.77
Affected/contralateral 0.87 O.l2a 1.00 0.02 0.99 0.01
a P < 0.005
These results can be explained by the glomerulotubular imbalance of
the ischemic kidney and seem to be useful for the functional and
etiologic evaluation of unilateral hypertensive kidney disease.
Role of bone scintigraphy (BS) in the diagnosis of renal osteodystrophy.
J. Botella, R. Lauzurica, J. Fernandez-Fernandez, D. Sanz-Guajardo,
J. L. Gallego, J. Ramos, and P. Lorenz, Clinica Puerta de Hierro,
Madrid, Spain. The data from 109 BS performed with Tc MDP in 69
patients under periodic hemodialysis (HD) were analyzed. The BS were
studied by independent observers without previous knowledge of the
patients, who were grouped as follows: A, N = 19, increased uptake of
the isotope in the skull and limb bones; B, N = 43, uptake increased in
viscera and decreased in bones; C, N = 42, moderately increased
uptake in viscera and bones. Five BS were considered normal. The
analysis of the data of the three groups yielded the following differ-
ences: A vs. B results were: less time in HD, 34.99 22.6 vs. 53.28
23.53 months, P < 0.005; higher alkaline phosphatase levels, 184.16
105.06 vs. 126.14 80.8 mU/mi, P <0.005; higher PTHi levels, 21.61
26.07 vs. 3.50 2.45 ng/ml, P < 0.0001; less Tc retention in blood
(TB) 20.00 10.73 vs. 39.63 16.48%, P < 0.01; fewer fractures 0 out
of 19 vs. 16 out of 43, P < 0.01. C vs. A results were: lower alkaline
phosphatase 127.48 76.4. P < 0.01; lower P PTHi levels 6.57 7.84,
P < 0.01; higherTB 42.57 12.20, P < 0.01; more fractures, 14 out of
42,P < 0.005. C vs. B results were: difference only in PTHi levels, P <
0.05. In conclusion, three BS patterns were observed, two of them were
very well defined: A was suggestive of hyperparathyroidism; B was
compatible with osteomalacia; and the third, C, had mixed features.
Calcium and parathyroid hormone response after exposure to alumi-
num in continuous ambulatory peritoneal dialysis (CAPD). J. Cannata,
J. D. Briggs, B. J. R. Junor, and V. Cuesta. Renal Unit, Hospital
General de Asturias, Oviedo, Spain, and Renal Unit, Western Infirma-
ry, Glasgow, United Kingdom. During the past few years there has
been considerable interest in the relationships of aluminum (Al) to bone
disease, calcium (Ca) metabolism, and parathyroid hormone (PTH).
Accidental Al contamination of a batch of CAPD dialysate gave us a
unique opportunity to look further into these relationships. We studied
19 CAPD patients who were accidentally exposed to a high Al level in
the dialysate for a period of 1 month. We measured serially Al, Ca,
PTH, albumin and phosphorous. After the use of high Al dialysate for 1
month, the mean serum Al rose from 1.86 1.65 to 7.11 4.09smoles/
liter (P < 0.0005). Over the same period the mean serum Ca rose from
2.27 0.24 to 2.44 0.21 mmoles/liter P < 0.0025). The mean serum
PTH fell from 744 599 to 580 580 ng/liter, but this difference was
not significant. Fourteen out of the 19 patients had a more marked Al
increase with a mean value of 9.10 jsmoles/liter. In this group, the serum
Ca increase was considerably greater and the fall in PTH was significant
(from 741 601 to 485 340 ng/liter, P < 0.05). Following a return to
Al free dialysate for 2 months, the mean serum Al fell to 1.92 1.38
smoles/liter and the mean serum Ca to 2.22 0.18 mmoles/liter. These
levels were significantly less than the peaks both for Al (P < 0.0025) and
Ca (P < 0.0025). There were no changes in Ca or vitamin D therapy
during the period of study or the preceeding 3 months. Neither were
there significant changes in serum albumin or phosphorous. Our
findings that the serum Ca increased and PTH decreased after a period
of Al exposure add strong support to the hypothesis that Al suppresses
PTH release by increasing serum Ca.
Aluminum hydroxide therapy, a real risk of aluminum toxicity. J.
Cannata, J. D. Briggs, B. J. R. Junor, J. Herrera, and V. Peral. Renal
Unit, Hospital General de Asturias, Oviedo, Spain, and Renal Unit,
Western Infirmary, Glasgow, United Kingdom. Aluminum hydroxide
[Al (OH)3] has been used for some time as a phosphate-binding agent in
chronic renal failure on the assumption that aluminum (Al) absorption
from the intestine is minimal. To investigate the consequences of long-
term Al (OH)3 administration, we measured the serum Al by electro-
thermal absorption spectrometry in 95 long-term hemodialysis (HD)
patients with a dialysate Al level of less than 0.3 smole. We found that
the patients could be divided into three groups according to their serum
Al levels. The table shows that the serum Al is related both to the
duration of HD and to the dose of Al (OH)3.
Serum Al
(moles/liter) Time on I-ID
Al (OH)3 intake (grams SEM)
I month 6 month Total dose
(no. ofpatients) (months sEM) dose dose on HD
<1.5 17.1 5Øb 83 13ac 519 96' 1627 504c
(19)
1.5—3.0 36.1 4.2b 96 8c 608 42a 3560 372c
(40)
>3.0 42.7 4.0 121 9a 729 54a 3911 461c
(36)
a P < 0.05
b P< 0.01
P < 0.0005
These findings would suggest a progressive increase in the risk of Al
toxicity with increasing duration of HD.
Effect of dietary sodium on renal PGE2 and PGF2 metabolism: Rela-
tionships with intrarenal hormone levels. S. Cantaro, L. Cola, L.
Bertazzo, A. Vianello, B. Baggio, and A. Borsatti. C/mica Medica 1,
Renal Laboratory, University of Padova, Padova, Italy. Assessing the
role of intrarenal hormones during changes in sodium intake is of
utmost importance in understanding hypertensive nephropathies. To
this end, three groups of 12 rats were fed a normal diet (NSI, 0.6 g
NaCI% + H20), a low sodium diet (LSI, 0.012 g NaCI% + H20), a high
sodiumdiet (HSI, 1.5 g NaCI% + saline) for a period of 15 days. On day
13 the rats were placed in metabolic cages and on day 15 urine was
collected for 24 hr; finally, kidneys were removed for tissue assays. We
assayed (expressed as milligrams of urinary creatinine): Na+, angioten-
sin converting enzyme (ACEu), kallikrein (Kall.u.), prostaglandin E2
(PGE2), prostaglandin F2 (PGF2), cyclic AMP (cAMP); in kidney
homogenates were assayed: phospholipase A2 (PLA2), kallikrein
(Kall.t.), prostaglandin E2 and F2,, synthetase activity (ETM and FTM,
respectively), PGE2 and PGF,,, catabolic rate (ETM and FTM, respec-
tively), angiotensin converting enzyme (ACE.t.). In a following study
some tissue parameters were assayed separately in the renal cortex and
in the medulla. No correlation between PLA2, ETM, or FTM and
urinary PGE2 or F2,, were found in all groups; good correlations were
found between urinary volume/die and POE2 in NSI rats and LSI rats,
and between urinary volume/die and PGF2 in HSI rats. There were no
correlations between ACE.t. and ACE.u. or Kall.t. and Kall.u. in all
groups. Urinary cAMP was higher in HSI rats (P = 0.05); in this group
it seems to correlate well with urinary sodium. Medullary ACE.t. was
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significantly higher (P = 0.01) in LSI rats and showed a good correla-
tion with medullary MET (P = 0.01) which was increased (P = 0.01) in
LSI rats in comparison with NSI rats. In HSI group ACE.t. (not
significantly differing with NSI), was well correlated with both MET (P
= 0.05) and MFT (P = 0.01). In conclusion, (1) there are no correlations
between PGE2, PGF2,,, ACE, Kall. tissue levels and urinary excretion;
(2) a faster niedullary anabolism in LSI rats and a faster degradation in
HSI rats; (3) ACE.t. (= kininase 2 ) is increased in LSI rats and
correlates with PGE2 and PGF2,. catabolic rate. The data suggest
concurrent effects of ACE.t. and PGs catabolic enzymes on sodium
excretion.
Arterial smooth muscle cell proliferation in renovascular hypertension:
Kinetics and reversibility. P. G. Carlier and G. L. Rorive. Department
of Medicine and Biochemistry, University of Liege, Liege, Belgium. A
cell proliferation wave occurs at a very early stage in the aorta of
Goldblatt 1-kidney, 1 clip hypertensive rats. After 4 days, the 3H-
thymidine uptake in vitro was 15.5 times higher than in controls; the
labelling index in vivo was 11.3 3.6nuclei %°against less than I % in
controls. The labelled nuclei were those of smooth muscle cells in small
groups widespread in the media. The transient character of the stimula-
tion was illustrated by a sharp increase followed by a stabilization of
DNA content which is found only in large arteries. The DNA synthesis
activity did not directly depend on BP since it disappears when HTA
stabilizes, but it is observed when the BP increasing rate (dPldt) is the
most dramatic. Moreover, the intensity of the stimulation was correlat-
ed to the slope of BP increase (nuclei %° = 0.27 BP mm Hg day 5—.
27.23; r = 1.0). In an attempt to obtain reversibility, the renal clip was
removed after 7 and 21 days, during and after the proliferation phase. In
both cases, BP normalized in a few hours. In the first case, an
improvement of the increase in aortic wet weight and in DNA content
was observed. On the contrary, no benefit was seen in late unclipping.
Aortic wet weight and DNA content remained at the previous level 15
days later. Finally, the action of several agents, alphamethyldopa,
clonidine, propranolol, atenolol, furosemide, prazosin, and captopril
were compared following the same protocol. No drug was able to
improve the aortic lesions when given after 21 days of HTA. Given after
7 days, all drugs but captopril and propranolol corrected BP efficiently.
All but prazosin reduced the heart hypertrophy. Only the centrally
acting agents, and to a less extent atenolol, limited the aortic hyperpla-
sia. The vascular benefit of an antihypertensive treatment cannot be
evaluated from the BP reduction but depends also on the drug used.
"Cold pressor test" effects on baroreflex function in patients with
essential hypertension. R. Carretta, B. Fabris, L. Tonutti, G. Bellini, G.
Battilana, A. Bianchetti, and L. Campanacci. Istituto di Patologia
Medica, University of Trieste, Trieste, Italy. The study was performed
to evaluate the effects of the 'cold pressor test" (CPT) on baroreceptor
sensitivity (BRS). For this purpose, BRS was assessed by phenyleph-
rine (BRSP) and amyl nitrite methods (BRSN), in nine patients with
essential hypertension and in nine controls before and during the
second minute of hand immersion in iced water. The table summarizes
the study results:
Controls Hypertensive subjects
MAP, mm Hg 87.5 11.0 109.8 13.0
HR. b/mm 66.0 8.0 68.0 6.0
MAP, mm Hg 18.3 5.0 16.0 7.0
LBRSP % 38.4 28.0 25.4 17.8
BRSN % 26.9 19.0
A B
27.4 19.2
A B
BRSP, mseclmm Hg 18.3 8.7 * 12.7 11.9 13.5 8.2 * 9.8 6.9
BRSN, mseclmm Hg 9.5 2.2 * 6.9 2.5 6.6 3.1 * 45 1.7
Abbreviations: MAP, mean arterial pressure; HR, heart rate; AMAP,
ABRSP, ABRSN, differences between MAP, BRSP, and BRSN before
and after CPT; A, parameters evaluated before and B, evaluated after
CPT.
* P < 0.05
Data analysis suggests the following conclusions: (1) the CPT results in
a BRS reduction both in hypertensive patients and controls; (2) for
similar increases of blood pressure, after CPT, BRS reduction does not
appear statistically different between the two groups; (3) the BRS
impairment, observed after CPT, seems related not only to the blood
pressure increase "per se" produced by the test, since it was found
similarly diminished even when BRS was assessed during blood pres-
sure reduction with amyl nitrite.
Infection of hepatitis B virus (HBV) and immune status in patients in
regular hemodialysis therapy (RDT). L. Catizone, G. Giuliani-Piccari,
E. Beltrandi, P. R. Dal Monte, and P. Zucche/li. Department of
Nephrology and Dialysis and Laboratory Service, M. Malpighi Hospi-
tal, Gastroenterology Unit, Bellaria Hospital, Bologna, Italy. We
studied 171 uremic patients in RDT from 2 to 168 months to correlate
the serological profile of markers of HBV infection (HBsAg, anti-HBs,
anti-HBc, HBeAg, and anti-HBe) with some immunological parame-
ters. Twenty-nine patients (16.9%) were carriers of HBsAg, with a very
high incidence of HBeAg (69.0%). Forty-nine subjects (28.6%) had anti-
HBs and anti-HBc, while 95 (55.5%) had only anti-HBc. At least one
marker of HBV infection was found in 103 subjects (60.2%). There was
no correlation between HBV infection markers and primary renal
disease, sex, age, period of dialysis, number of blood transfusions, and
previous immunosuppressive therapy. Most HBsAg carriers acquired
HBV infection after starting dialysis treatment, although the HB5Ag
carriers were in strict physical isolation in the dialysis center. No
patient received passive or active immunization. The immune state of
patients was investigated in carriers of HBsAg and in a similar group of
HBsAg negative uremic patients in RDT, evaluating the percentage and
absolute number of T and B lymphocytes by the rosette test (E, EAC)
and the lymphocyte function of PHA, Con-A and PWM responsiveness
in autologous plasma. The results show that lymphocytes from HBsAg
carriers have a significant hyporesponsiveness to mitogens compared
with those from the HBsAg negative subjects. The difference between
the two groups is greater if in the latter group we only consider the
HBsAg negative patients who also have markers of previous HBV
infection.
Follow-up of recurrent calcium stone formers by biochemical assays
and crystalluria study. R. Caudarella, G. Biagini, M. Maccaferri, N.
Malavolta, E. Rizzoli, F. Stefani, and G. D'Antuono, Istituti di
Patologia Speciale Medico II and Microscopia Elettronica Clinica,
Universitd di Bologna, Bologna, Italy. The biochemical laboratory
plays an important part in recognizing the cause of the urinary stones
and the continued management of stone formers. Metabolic study of
our patients with idiopathic calcium urolithiasis at present includes the
following determination: Ca, P04, Mg, Na, K, Cl, creatinine, urate,
alkaline phosphatase, proteins, osmolarity in the plasma; Ca, P04, Mg,
Na, K, Cl, creatinine, urate, osmolarity, GAGs, oxalate, glycolate, and
citrates in 24-hr urine. A fresh urine sample was collected into a dry
thermos flask for crystal and pH evaluation; if crystals were absent we
performed the evaporation test according to the Hallson and Rose
method. Whereas with biochemical data determinations it was possible
to monitor the effects of therapy (that is, a statistically significant
decrease in urinary calcium and crystalluria by thiazides, a reduction of
uricosuria and oxaluria by allopurinol, and so forth), the evaluation of
single parameters only was inadequate to determine the stone disease
activity. Nevertheless, it is possible to study the disease activity by risk
indexes as well as by observation of crystals in urine before and after
evaporation. By means of an evaporation test it is in fact possible to
evaluate lithogenetic activity also without evident metabolic modifica-
tions, providing a useful aid in therapeutic management.
Hemodiafiltration (HD/HF) versus hemofiltration (HF). L. Ciani, M.
Maccheroni, G. Paleologo, D. Palmarini, N. Pilone, P. Rindi, and G.
Rizzo. Division of Nephrology, S. Chiara Hospital, Pisa, Italy. Eight
uremic patients undergoing chronic HF by PAN hollow fiber hemofilter
m2 1.4 were then treated by HD/HF using the same filter model. In both
treatment protocols the same method was used for ultrafiltrate rate (100
to 110 mI/mm), reinfused polisaline solution with postdilution method
(ranging from 24 to 27 liters for each session), Q8 (400 mI/mm), TmP
(500 mm Hg). During HDIHF, QD was 500 mI/mm. A significantly
higher removal of low molecular weight solutes was obtained with this
technique than with HF, as shown in the table below. The table shows
mean values of the percentage decrease of some toxins in the plasma of
the patients studied during a single session.
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HF HD/HF
Urea 54 83
Creatinine 52.6 73.6
Uric acid 51 70
Inorganic phosphorous 38 46
In conclusion, it can be suggested that this HD/HF method is much
more efficient than HF, and, therefore, it can be employed to reduce
treatment time required for the removal of these uremic toxins.
1-Alpha-hydroxycholecalciferol (1-alphaOHD3) in the treatment of
secondary hyperparathyroidism of predialytic chronic renal failure
(CFR). G. Coen, G. Bianchini, S. Mazzaferro, F. Messa, D. Finislauri,
G. Giuliano, C. Massimetti, and G. A. Cinotti. Division of Nephrology,
Clinica Medica 2, University of Rome, Rome, Italy. Treatment with
1 .25(OH)D3 of secondary hyperparathyroidism (SH) in predialytic
CRF has been reported to aggravate the rate of deterioration of renal
function. This study was performed on nine patients, aged 22 to 75
years, affected by CRF with a GFR of 22.79 10.5 (SD) and serum
creatinine of 4.04 1.9 mg/dl. The patients were started on a diet with a
protein and phosphate content, respectively, of 0.6 g/kg and <800 mg.
In addition they received daily ito 1.5 g calcium p.o. Treatment with 1-
alphaOHD3, 0.25 to 0.5 .tg/day was conducted for 11.94 4.8 months.
During the period of observation all the patients exhibited a highly
significant linear decrease of the reciprocal values of serum creatinine
levels (1/Cr) with time. In eight patients the timecourse of 1/Cr values
was also evaluated before the beginning of treatment, for a period of
21.2 12.8 months. The test of signs carried out on the pre- and post-
treatment slopes did not show any statistical difference (P = 0.50). The
same conclusion could be drawn from the (test for paired data (P =
0.20). Treatment induced an increase of serum calcium levels (8.88
0.89 to 9.29 0.37 mg/dl) and a fall in serum iPTH in seven of eight
patients. In two patients an episode of hypercalcemia had a transitory
effect on creatinine levels. In another group of four patients with a GFR
comparable to the experimental group, treated only with the low protein
and phosphate diet and calcium p.o., a significant increase in serum
iPTH levels occurred during the observation period. In conclusion,
treatment of predialytic CRF with l-alphaOHD3 is effective in the
control of secondary hyperparathyroidism, while not showing any
durable adverse effect on the spontaneous rate of decline of renal
function.
Endogenous synthesis of 24,25(OH)2D3 (24,25D) is not effective on
hemodialysis osteodystrophy (HO) during treatment with 250HD3 (25D)
and 1,25(OH)2D3 (1,25D). G. Coen, M. Taccone Gallucci, E. Bonucci,
P. Ballanti, G. Bianchini, S. Mazzaferro, D. Palmiotti, C. U. Casciani,
and G. A. Cinotti. Division of Nephrology, 5th Surgical Pathology, 5th
Anatomical Pathology, University of Rome, Rome, Italy. In our
experience the administration of 25D + 1 ,25D is more effective than
1 ,25D alone in HO. To evaluate whether endogenous 24,25D plays a
role in the therapeutic effect of the metabolites, serum 24,25D was
measured in 40 patients on HD. Twenty-one patients (A) did not receive
D or D metabolites; ten (B) received 1,25D (0.25 to 1 pg/day), and nine
(C) 25D (0.5 to 0.75-pg/kg/day) and l,25D (0.5 to 2 pg/day). Bone
biopsy for histomorphometry was made basally and after 6 to 12 months
of treatment. The serum D metabolites were assayed after at least 1
month of treatment. The results are reported in the table below:
24,25D,
Groups ng/ml 25D, ng/ml 24,25D/25D r P
Normal (18) 1.87 0.24 13.58 1.56 0.149 0.180 0.56 0.05
A (21) 1.31 0.18 16.58 2.16 0.092 0.014 0.59 0.01
B (10) 2.73 0.34 27.99 5.04 0.122 0.019 0.29 NS
C ( 9) 3.53 0.71 145.19 23.35 0.023 0.003 0.61 NS
In addition in patients B and C no correlation was found between serum
24,25D levels reached in the course of treatment and the decrease of
PTH and resorption surface obtained at the end of treatment. In
conclusion in RD patients 24,25D and 25D were positively correlated.
Administration of 1,25D raised serum 24,25D levels, while 25D even at
high doses had no additive effect on this parameter. The therapeutic
effect of 25D and I ,25D on HO are not mediated by an increased
endogenous synthesis of 24,25D.
Analysis of IgA1 and IgA2 subclasses in circulating immune complexes
and serum immunoglobulins of Berger and Henoch-Schönlein glomerulo-
nephritis. R. Coppo, B. Basolo, M. R. Buizomi, G. Monga, F. Giac-
chino, M. Messina, and G. Piccoli. Department of Nephrology and
Pathology Institute, the University of Turin, Nephrology and Dialysis
Units, S. Giovanni Hospital, Turin, Italy. IgA subclasses have been
considered as markers of the origin of mesangial deposits in IgA
nephropathy (Berger GN) because of their different concentration in
sera and mucosas. No analysis of IgA subclasses in IgA containing
circulating immune complexes (IgAIC) or in A immunoglobulins (IgA)
has so far been presented. For this purpose we performed this study on
31 patients with Berger GN (BGN) and 14 Henöch-Schonlein GN
(SHGN) by investigating: (1) IgA1IC and IgA2IC (modified congiutinin
solid phase assay), (2) IgA1 and IgA2 immunoglobulins (immuno
enzymatic assay), (3) polymeric IgA (reduction-alkylation test). In both
groups of patients mean levels of IgA1IC and IgA2IC were significantly
greater than controls. The correlation of these data with clinical phases
of activity was good. In the clinically inactive stage of the disease only
slight amounts of IgA1IC were found. In the active phase both tgA1lC
and LgA2IC increased in BGN and in SHGN, but the levels of IgA1IC
observed during clinical activity were significantly higher in the SHGN
than in the BGN group. During episodes of macroscopic hematuria both
IgAIC subclasses increased at the same rate. Patients with a past
history of recurrent gross hematuria had predominantly IgA2IC, when
they were studied in the inactive stage. The IgA1/igA2 ratio in immuno-
globulins was found not to differ from controls in either group of
patients, nor was it correlated with the lgA1lC/IgA21C ratio. An
increase of polymeric IgA was observed in 30% of BGN and in 50% of
SHGN. These data add further support to the hypothesis of a mucosal
origin of IgAIC in IgA glomerulonephropathies and suggest that some
differences in the immunological aspects found between BGN and
SHGN might account for different clinical courses.
Renal lesions in patients treated with mitomycin C. Cooperative study
of the Société de Nephrologie. D. Cordonnier, Grenoble, France.
Seventeen patients with carcinoma were registered in 26 nephrological
centers in France (12 women, 5 men, age 21 to 70; mean age, 53). The
study included carcinoma of breast (8), stomach (5), colon (I), gut (I),
and liver (I). Carcinoma was considered in remission eight times when
mitomycin C (MC) was begun. Five patients with breast carcinoma had
roentgentherapy associated. Numerous drugs were used together with
MC, namely fluoro-uracile (9 patients) or methotrexate and teniposide
(Vehem R) (8 patients); doses of MC varied from 10 to 14 mg/rn2 in two
to nine monthly treatments. The disease appeared 4 to 20 months
(mean, 8.3) after the beginning of the treatment and 0 to 2 months after
the last MC treatment. The role of blood transfusions in inducing the
symptoms might be probable in three patients. The disease was closely
similar to a hemolytic and uremic syndrome with hemolytic anemia,
schizocytes (9 out of 12), low or very low haptoglobinemia (II out of
13), thrombopenia (14 out of 17), proteinuria (17 out of 17), hyperten-
sion (16 out of 17) and renal failure with or without oliguria (creatinine-
mia: 160 to 600 jsmoles/liter). Extrarenal symptoms included lung
involvement (four with edema and five with interstitial acute pneumo-
nias) and peripheric neurological involvement (three patients). Evolu-
tion may be classified in three groups: (1) three rapid deaths due to MC
disease and four chronic dialysis were observed in patients with low
platelet counts (<50 giga/liter); (2) six stabilizations: creatinine remain-
ing at its initial level after remission of hematological signs; (3) four
hematologicai and then renal improvements. The role of plasma ex-
changes in five of these patients should be considered. Pathology: 11
biopsy specimens were obtained from te patients. Endotheliolysis and
mesangiolysis appear very often, sometimes in little segments, with
nuclear dysmorphic aspects and a double contour pattern; a pale
subendothelial or intramembranous proteinaceous deposit is constant.
In addition six of these patients may be classified as renal thrombotic
microangiopathy (TMA). Such a finding seems to have no prognostic
value because only one had a poor evolution and the best course was
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observed after a severe TMA. A second biopsy specimen showed
disappearance of TMA 1 year later. In conclusion, such a cooperative
study brings information of two types (1) positive, the poor prognostic
value of clear thrombopenia (<50 gigalliter) (2) negative, compilation of
observations from different origins gives a relative value to etiological
factors, clinical symptoms, or pathological data which in isolated cases
may have seemed to be of great importance.
Renal function differences between young normotensive offspring of
two hypertensive and two normotensive parents. D. Cusi, C. Barlassina,
C. Vezzoli, C. Pati, M. Gatti, P. Lupi and G. Bianchi. Istituto di C/mica
Medica 1, Scuola di Specializzazione in Nefrologia Medica, Universitâ
di Milano, Italy. To distinguish between primary and secondary
changes of kidney function in essential hypertension, we studied two
groups of young normotensive subjects, well matched for age, sex,
body surface area, but differing in family history of hypertension. In one
group (HP, 65 subjects) both parents were hypertensive, while in the
other (NP, 55 subjects) both parents were normotensive. Blood pres-
sure, renal plasma flow (RPF), glomerular filtration rate (GFR), plasma
renin activity (PRA), plasma catecholamine in supine and upright
positions, urinary Na, K, aldosterone, plasma volume, and cardiac
output were measured. When compared to NP, the HP have faster RPF
(756.7 31 mI/mm vs. 655 16, P <0.01), faster GFR (139.8 3.6 ml!
mm vs. 126.1 3.7, P < 0.01), lower PRA (0.8 0.07 ng An-
gio1 ml h vs. 1.56 0.3, P < 0.01), and higher urinary output
(1060 40 ml/24 hr vs. 949 33, P < 0.05). The other parameters
measured were similar in the two groups. On a smaller number of
subjects (15 HP and 10 NP) fractional Na excretion (FENA%) in basal
conditions and after isotonic saline load (0.4 ml min kg BW' for 1
hr) was also measured. The mean values of the basal and post-loading
FENa% were similar among HP and NP. When an arbitrary value of
FENa% after saline load was set at 2.65, the HP with FEN% smaller
than 2.65 have faster basal RPF than the HP with FEN% greater than
2.65 (745.7 23 mI/mm vs. 656.6 26, P < 0.05). The selective kidney
functional alterations in HP suggest that an intrinsic alteration in tubular
handling of ions and water is present before the development of
hypertension and may be involved in its subsequent development.
A new association: Ankylosing spondylitis (AS) and Berger disease
(BD). S. Dard, S. Kenouch, J. P. Mé,y, A. Baumelou, H. Beaufils, and
A. Baglin. Hôpital Bichat et Hôpital de la Pitié, Paris, et Hôpital
Ambroise Pare, Boulogne, France. The association of AS and BD has
been observed in four male patients. Their main clinical and biological
data are given in the following table:
Age at the CRF BP
Patient
discovery of the
1st symptoms
Follow-up
At the end
of the
nos. Articular Renal years follow-up 515A
1 15 15 15 + + I
2 32 39 22 — +
3 14 16 9 — — I
4 35 35 17 — — 1'
Patient no. 4 suffered also from ulcerative colitis. The first symptoms
occurred a few months after urinary abnormalities were discovered.
The association of SA and BD is not likely to be accidental since seven
other patients were found in the literature. It is possible to consider a
common pathogenesis for the two diseases. Both of them frequently
follow an infection of either the respiratory or the gastro-intestinal tract
and are associated with a rise in serum IgA. An increase in the synthesis
of polymeric IgA by the plasma cells located in these mucosae could be
triggered by a specific antigenic stimulation. Then both AS and BD
could be the consequence of the deposition of IgA-containing circulat-
ing immune complexes in the joints and the kidneys, respectively. An
antigen from Yersinia enterolitica, infections that are often followed by
the development of spondylarthropathies, may be responsible in some
cases. There are strong arguments that in the association described
above BD bears no relationship to the HLA B27 antigen.
Sexual disturbances among uremic women on hemodialysis. L. De
Besi, E. Serafini, S. Zussa, M. Chini, L. Gasparotto, S. Lorenzi, M.
Seriani, G. Ancona, G. La Greca, E. Saporiti, G. F. Romagnoli,
Adami, P. Zucchetta, and I. Mastrogiacomo. 1st. Semeiotica Medica,
Universitd di Padova, and Servizio Emodialisi 0. C. Conegliano,
Padova, and Venezia, Vicenza, Verona, Italy. Although it is well
known that uremic men on hemodialysis frequently complain of sexual
disturbances, few if any data are available for women. One hundred
thirty-one women on maintainance hemodialysis were given a standard
questionnaire enquiring about the frequency of sexual intercourse, the
ability to reach orgasm, the degree of libido, the eventual occurrence of
dyspareunia, compared to their predialysis state. One hundred valid
answers concerning married and cohabiting women were examined.
Eighty-three percent reported an impairment in the ability to reach
orgasm, 80% a more or less marked decrease of libido, and 20%
dyspareunia. The mean frequency of intercourse/month varied from 5.6
to 3.2 before dialysis and after initiating treatment was markedly lower
than that of normal aged-matched individuals. To study the mechanism
by which such disturbances are established, blood prolactin level was
determined in 68 subjects. Hyperprolactinemic (hPRL > 25 ng!ml)
patients reported hypo-orgasmia or anorgasmia in a slightly higher
percentage (30 out of 33) than that of normoprolactinemic ones (27 out
of 35). The frequency of sexual intercourse was significantly lower in
the patients with hyperprolactinemia, whereas there were no significant
differences for dyspareunia and decreased libido.
Mean frequency of sexual intercourse/month
Age ranges Normal hPrl Hyper hPRL Control
35 to 44 years 6.2 3.4 6.8
45 to 54 years 3.7 2.8 4.8
Over54years 3 1.3 2.8
Inhibition of renal prostaglandins in seven children with nephrogenic
diabetes insipidus. M. Dechaux, C. Trivin, M. Broyer, D. Leroy, M. F.
Gagnadoux, and P. Niaudet. Hôpita/ des Enfants Malades, Paris,
France. Seven children (three girls and four boys), 15 months to 14
years old (mean, 7 years), suffering from primary nephrogenic diabetes
insipidus (NDI) (urinary concentrating ability after dDAVP: 44 to 126
mOsm!kg) were treated by oral administration of indomethacin (I), 3
mg/kg/day. Before and after 8-day I treatment, creatinine clearance
(Ccr), osmolar clearance (C0,,,), free water clearance (CH2O), Na
delivery (CH20 + CNa), distal Na reabsorption (CH20!CH2o + CNa),
urinary prostaglandins, and cAMP were measured before and after the
dDAVP test. With I, we observed a significant decrease (P < 0.01 of
Ccr, mean —11%), V (—32%) and of Na delivery (—39%). No significant
modification of distal Na reabsorption was noted. Mean urinary osrno-
lality increase with I was 26% (P < 0.01, range 9 to 40%). dDAVP
administration in patients treated with I resulted in a significant increase
(P < 0.01) in maximum urine osmolality (mean + 50%). In conclusion,
we have observed that maximum concentrating ability has been im-
proved with I in children with severe NDI. The authors suggest that
inhibition of prostaglandin synthesis induces an increase in Na proximal
reabsorption which is probably at least one of the mechanisms involved
in the I action.
Diagnostic and therapeutic problems in renovascular hypertension. G.
Del Rosso, M. Maccarone, and A. Albertazzi. Department of Nephrol-
ogy and Dialysis, "SS. Annunziata" University Hospital, Chieti, Italy.
From laboratory tests performed on 299 hypertensive patients we
selected 30 subjects with suspected renal or renovascular hypertension
by evaluating peripheral renin activity and/or pyelography. Renal
venous renin activity was estimated. In 18 patients complete lateraliza-
tion of renin production was shown, surgery was indicated and angiog-
raphy was performed. Twelve patients had renal artery stenosis, five
chronic unilateral pyelonephritis, and one reninoma. Revascularization
was performed in nine, an autotransplant in three, and nephrectomy in
six. During a 5-year follow-up period after surgery, good blood pressure
values in 72% were observed during the first 12 months. After 12 to 24
months all patients with arteriosclerotic renovascular hypertension
needed medical therapy, while the others showed satisfactory blood
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pressure values up to 60 months without drug therapy. Of the remaining
12 patients, five with normal venous renin activity received successful
routine drug treatment; the other seven, with nephroangiosclerotic
contralateral kidney with variable impairment of renal function and
elevated venous renin values, were treated with captopril alone or
combined with diuretics, and good pressure values were obtained.
Studies on the hypothalamic origin of a natriuretic.pressor substance.
J. Diez, P. Errasti, J. Villaro, and A. Purroy, Servicio de Nefrologia,
C/mica Universitaria, Pamplona, Spain. The aim of the present study
was to investigate a hypothetical relationship between changes in
hormonal synthetic activity of the hypothalamus (HT) and variations in
sodium (Na) excretion and blood pressure (BP). Metabolic activity
(MA) of cells of different regions of the HT was analyzed as an index of
its hormonal synthetic activity. Experiments were performed in three
groups of ten Wistar rats each: contol rats (group 1), conscious rats
submitted for 2 hr to isotonic volume expansion with saline solution
(group 2), and anesthetized rats submitted for 2 hr to an infusion of Na-
rich cerebrospinal fluid into the lateral cerebral ventricle (group 3). MA
of the hypothalamic cells was evaluated according to the measurement
of the nuclear cellular area (NCA) in histological preparations obtained
after the experimental procedures in all groups. Changes in NCA were
considered as an index of MA. As compared to group I, group 2 showed
an increase in Na excretion (P < 0.001), an increase in BP (P < 0.001)
and an increase in NCA of anterior HT cells (P < 0.005). No changes
were observed in medial and posterior HI cells. In group 3 there was an
increase in Na excretion (P < 0.001), BP increased but not significantly
and an increase in NCA of anterior HT cells was observed (P <0.001).
No changes were observed in medial and posterior HT cells. It is
concluded that in some experimental conditions there is a relationship
between increases in Na excretion and BP and an increase in MA of
anterior HI cells. These observations suggest that an increase in an
undetermined hormone synthetized by the anterior HT could influence
the variations of urinary Na and BP.
Unusual presentation of Fabry disease: Rapidly progressive glomerulo-
nephritis associated with granulomatous hyperplasia of gums. E. Dupont,
P. Daelemans, V. Thoua, Y. Preudhomme, N. Van Regemoorter, I.
Liebaers, P. Vereerstraeten and C. Toussaint, HOpital Erasme, Univer-
site Libre de Bruxeiles and Academisch Ziekenhuis, Vrije Universiteit
Brussel, Brussels, Belgium. A 25-year-old male patient, presenting with
isolated proteinuria (1 to 2 g/day) and mild renal insufficiency (serum
creatinine concentration 1.9 mgldl), was submitted to kidney biopsy in
May 1980; microscopic examination revealed focal hyalinosclerosis.
Renal function gradually deteriorated within 2 years and regular dialysis
treatment was initiated in March 1982. At that moment, thorough
evaluation demonstrated Fabry disease. Hyperplasia of the gums was
present at physical examination of the patient. Biopsy specimens of
gums and conjunctivae showed massive plasmocytic infiltration, epithe-
bid granulomata with giant cells, and accumulation of lipophagic cells
in the vessels. Reappraisal of the kidney biopsy obtained in 1980
showed spumous epithelial cells in the gbomeruli, as observed in Fabry
disease. Enzymatic studies revealed a specific a-galactosidase deficien-
cy in the serum and white blood cells of the patient as well as of the
patient's brother, aged 26, who had experienced abdominal pain and
acroparesthesias during the past 10 years. The renal function was
normal but mild intermittent proteinuria was found. This patient record
shows that Fabry disease may initially exhibit signs suggesting idiopath-
ic glomerular disease, but it is rarely associated with granulomatous
hyperplasia of the gums and conjunctivae.
Urinary pattern in hypertension: Proteinuria and enzymuria. L. Fac-
cmi, R. Rustia, M. Carraro, E. Englaro, G. Battilana, A. Rigoni, E.
Puppis, G. Bellini, and L. Campanacci. Istituto di Patologia Medico
deli Universitd di Trieste, Trieste, Italy. Previous study has shown that
slight glomerular proteinuria (less than 1 g/24 hr) is present in urinary
samples of essential hypertensive patients. We have confirmed this
observation in a study of 130 urinary protein patterns of essential
hypertensive patients with normal kidney function using Cellogel RS
electrophoresis. A glomerular proteinuria (albumin and transferrin) was
present in 19% patients, a mixed proteinuria was observed only during
urinary tract infection while no tubular proteinuria was present as
reported by other authors. This possible tubular damage was further
studied in a group of 21 hypertensive patients (10 men and II women)
with a mean age of 49.6 9 (range, 26 to 65 years) with normal kidney
function who had hypertension for more than 2 years. All drug therapy
was discontinued at least 3 weeks before starting the study. Systolic
blood pressure ranged from 160 to 205 mm Hg (mean value, 178.57
14.06) and diastolic from 100 to 135 mm Hg (mean value, 111.9 9.93).
Techniques for urinary total protein (Ponceau S dye binding), /32-
microgbobulin (RIA), a-glucosidase (Franzini and Ceriotti) and lyso-
zyme (Prockopp) and Cellogel RS electrophoresis, respectively, were
used. No increased urinary a-glucosidase (parenchymatous protein-
uria), f32-microgbobulin, and lysozyme (tubular proteinuria) excretion
could be observed, in comparison to normal subjects. Cellogel RS
electrophoresis showed a glomerular pattern in four of the 21 patients
and a normal pattern in the others. Mean urinary total protein content
was similar to that of controls. Our data confirm that in hypertensive
patients with normal renal function proteinuria, if present, is of the
glomerular type, while tubular damage is generally absent.
Hypomagnesemia: A usual manifestation of cis-platin (CP) nephrotoxi.
city. F. Fernández Vega, F. Ortega Suárez, A. Panizo ,andJ. Alvarez
Grande. Division of Nephrology, C. S. Ntra Sra Covadonga, Oviedo,
Spain. Eleven males with lung cancer aged from 35 to 67 years ( SEM
= 51.9 3.4) were studied. The total number of courses was 61. Each
patient received from 2 to 12 courses (5.54 1.14) and from 160 to 1440
mg/m2 (719 l36) of CP. Follow-up was from 2 to 13 months (6.18
1.2). If serum creatinine (Cr) was higher than 1.5 mg/dl and creatinine
clearance (Cr) lower than 70 mI/rn, CP was not given. During 12 hr
before CP administration, 3 liters of intravenous glucosaline plus 250 cc
of mannitol 10% were given by continuous infusion. After every CP
course and during another 12 hr, patients received 4 liters of glucosaline
solution plus 80 mEq of potassium chloride plus mannitol. If serum
magnesium (Mg) < 1.7 mgldl and bicarbonate <23 rnEq/biter, hypomag-
nesemia and metabolic acidosis were diagnosed respectively. The high
normal limit of anion gap was 16 mEq/biter. Hypomagnesemia was seen
in nine (81.8%) patients. It was usually present at the last CP courses. A
mild increase of Cr appeared in three patients. The highest Cr was 1.67
mg/dl and C. 57 mI/rn. There was metabolic acidosis in eight patients,
six of whom had urine pH >6.5 (distal renal tubular acidosis, DTA). All
our patients showed an increased anion gap. In conclusion, (1) CP
severe nephrotoxicity can be avoided with previous extracellular ex-
pansion. (2) However, tubular damage, shown as hypomagnesemia or
probable DTA, is present in the majority of patients.
Treatment of peritonitis (PT) in peritoneal dialysis (PD): Comparison
between continuous lavage with machines (CLM) and four bags per day.
J. F. de Fremont, D. Thomas, H. Dkhiss, P. Fievet, P. F. Weestel, A.
Pruna, B. Coevoet, A. Fournier, andJ. Orfila. Service de Nephrologie
et de Bacteriologie CHU Amiens, France. Forty-five patients were
treated by PD. Fifty-one episodes of PT occurred. The first 26 PT
(group A) were treated by CLM (40 liters/day) and in situ antibiotics
(AB). In the absence of candida the association of sulfamethoxazol
(SMZ: 80 mg/liter) and trimethoprime (TMP: 16 mglliter) was used.
Only when a candida was present, was amphotericine B (AMB: 5 mg/
liter) used. CLM was continued until PT was cured. The last 25 PT
(group B) were treated with four bags/day of CAPD with in situ
AB:SMZ: 200 mg/liter and TMP: 40 mg/liter, and routine candida
treatment consisted of AMB 1.5 g/day. The results are in the following
table:
PT Group
Inciden
A
ce of PT
B
Delay for cure, days
A B
Aseptics
Gram positive
Gram negative
Candida
38%
42%
12%
8%
16%
48%
36%
0%
6
6
14
51
4
8
3
11
7 35 2
10 6
0
Five patients of group A and two of group B died. In group A, the AB
was changed in nine patients because of initial resistance (three
patients) or bacterial superimposed infection (two patients) or candida
superimposed infection (four patients). In group B the AB was changed
in five patients because of initial resistance and in two patients because
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of candida superimposed infection. In conclusion, (I) the treatment of
PT with four bags per day and in situ AB cures PT as rapidly as CLM
despite lower total doses of SMZ-TMP. (2) Since this method is also
less painful and easier to perform, it appears to be the treatment of
choice. (3) The usefulness of candidiasis prophylaxis is suggested but
not proved statistically.
Plasma exchange in myeloma renal failure. D. Ganeval, P. Jun gers,
M. Cathomen, D. Lemau, and D. Rebibo. Hôpital Necker, Paris,
France. Myeloma (M) renal failure (RF) often worsens, sometimes
irreversibly, before the favorable effect of chemotherapy can be ob-
tained. The immediate effect of plasma exchange (PE) in removing light
chains responsible for RF makes it a logical treatment in such cases. We
used this treatment for nine patients, five male and four female, aged
from 49 to 79 years (mean, 63), who had M with RF. M type was IgGA
(1), IgAX (1), X (4), K (3); all patients had BJ proteinuria. RF and M were
discovered simultaneously in all patients, either < 1 month (6 out of 9)
or 3, 8 and 9 months before PE. Renal biopsy in six patients showed: M
kidney with casts in three, and light chain deposition disease (LCDD) in
three. PE was initiated when RF worsened or did not improve despite
rehydration and alkalinization associated with chemotherapy. Each PE
procedure (using a cell separator, Haemonetics 30) exchanged approxi-
mately 2 liters of plasma with albumin and fresh frozen plasma. Each
patient underwent two to nine procedures (mean, 6), three per week.
Results were as follows: (1) RF in two patients [plasma creatinine (Per)
400 and 440 pimoles literl remained stable and in four patients (Pcr 800
to 1390 .t/moles liter) improved progressively during PE. Improvement
continued in these six patients after PE (Pcr 280 to 530 zmoles/liter);
four out of six survived at 4 to 36 months (mean, 17), two died at 11 and
26 months; renal function remained unchanged in all six; (2) RF did not
improve with PE in three patients; all died < 1 month after PE, (sepsis,
one, and multiple organ dysfunction, two. Autopsy of the two latter,
where renal biopsy showed LCDD kidney, revealed diffuse systemic
deposition of light chains). In conclusion, improvement of renal func-
tion occurred simultaneously with plasma exchanges in several patients
who had myeloma with rapidly progressive renal failure unresponsive
to rehydration and alkalinization. This observation deserves further
investigation by a controlled, prospective study.
Membranoproliferative glomerulonephritis in cirrhosis: Good evolu-
tion after corticoid therapy and plasmapheresis. C. Genin, J. C. Saba-
tier, B. Laurent, P. Laurent, R. Gonthier, and F. Berthoux. Service
Néphrologie. CHU Saint Etienne, France. Eight patients with cirrhosis
and glomerular lesions were studied. Cirrhosis was diagnosed from
hepatic biopsy (five patients) or from a typical clinical and biological
state (three patients). All the patients had urinary signs: variable
proteinuria (0.5 to 4 g/24 hr) and gross hematuria (four patients) or
microscopic hematuria (four patients). The renal function was disturbed
in six patients. Renal biopsy displayed mesangial glomerulonephritis
(five patients) or membranoproliferative type I glomerulonephritis
(three patients) always associated with predominant mesangial IgA
deposits by fluorescence. The three patients with membranoprolifera-
tive type I glomerulonephritis had a disturbed renal function. Serum
IgA was markedly increased. The complement was normal. The circu-
lating immune complexes studied by Clq precipitation with PEG 2%
were detected in two patients out of three. These three patients with
membranoproliferative type I glomerulonephritis had a good evolution
after they interrupted alcoholic consumption and were treated with
more than 4.5 g of methyiprednisolone and plasmapheresis. In two
patients the urinary signs and the renal failure disappeared or improved
significantly, the glomerular lesions recovered but vascular and intersti-
tial lesions persisted in one control biopsy 3 years later.
Does uremia increase malignancy? F. GiacchinO, F. Quarello, G.
Giachino, P. Bossi, S. Alloatti, and G. Piccoli. Nephrology and
Dialysis Unit, San Giovanni Hospital, Torino, Italy. Several recent
studies have reported an increase in malignancy in uremia, yet the
mechanism by which uremia produces this effect stilt remains to be
explained. To evaluate this phenomenon, we studied 211 patients (154
males, 57 females; mean age, 56 11 years) on chronic hemodialysis
for an average of 42 15 months. Nine tumors were found in nine
patients, a significantly higher figure (P < 0.01) than the average in the
age-matched general population (148 per 100,000 in the Turin Cancer
Registry). In two patients the onset of the tumor preceded dialysis
treatment, in seven patients it began 10 to 19 months after. In eight
patients we determined the immunological status using the DNCB and
PPD skin tests and the spontaneous and active E-rosette count. Eight
out of eight patients were DNCB negative, six out of eight PPD
negative; the number of E-rosettes was low (20 8%) in eight out of
eight patients as also the active E-rosette count (25 4%). Can cellular
immunodeficiency thus be said to influence increased malignancy in
uremia?
Effect of cis-platinum (CPDD) on human kidney proximal tubule as
studied through enzymuria. M. Giannattasio and P. Coratelli. Istituto di
Nefrologia Medica-Universita' Degli Studi, Ban, Italy. Nephrotoxicity
of CPDD has prevented its extensive use in the treatment of cancer.
Therefore, we studied renal function of seven patients with ovarian
carcinoma, treated with courses of antiblastic chemotherapy consisting
of cyclophosphamide and CPDD (50 mg/mEq body surface area). Every
patient was submitted to two to seven cycles of antiblastic therapy for 2
to 7 months. Altogether 20 courses of chemotherapy were studied. No
drugs were administered to produce diuresis. Renal function was
monitored by serial determination of plasma creatinine, BUN, protein-
uria and, to find early evidence of nephrotoxicity, urinary enzyme
pattern consisting of three brushborder membrane enzymes [alkaline
phosphatase(AP), gammaglutamyltranspeptidase (y-GT), alanine-ami-
nopeptidase(APP)]. No significant change was found in the mean value
of plasma creatinine, BUN, 24-hr protein excretion, and in urinary
protein electrophoresis; on the contrary, a high output of urinary
enzymes after CPDD administration was observed. There was no
significant statistical difference between increased AP and y-GT excre-
tion and respective mean pre-treatment levels, while AAP excretion,
which was already significant on the first day of CPDD administration
(P < 0.05), reached peak value on the second (P < 0.01). Enzymuria
returned to pre-treatment value on day 4 after CPDD administration.
Results suggest that CPDD, at the dose employed, is toxic for the
proximal tubule, but its nephrotoxicity is only potential and wholly
reversible. Enzymuria has a great diagnostic value for monitoring
CPDD chemotherapy, particularly when administered to patients with
impaired renal function.
Place of renal radloisotopic exploration with 99 Tc DTPA in the study
of renal hypertension. R. Gonthier, A. Champailler, J. Juge, T. Herr-
mann, C. Genin, J. C. Healy, and F. C. Berthoux. Service de
Nèphrologie and Service Central de Médecine Nucléaire, CHU, Saint
Etienne, France. To evaluate the clinical validity of renal scanning
exploration with 99'" Tc DTPA, we studied 60 patients with hyperten-
sion, classified as follows: (1) renovascular hypertension (22 patients);
(2) chronic pyelonephritis with or without obstruction (11 patients); (3)
renal dysplasia or hypoplasia (12 patients); (4) hypertension due to
bilateral parenchymatous nephropathy (15 patients). There is a good
correlation between the creatinine clearance/day! 1.73 m2 and the total
DTPA clearance (N = 60, r = 0.65, P < 0.001). There is also a signifii-
cant correlation between the respective surface of each kidney mea-
sured on x-ray film (either IVP or arteriography) and the separated
clearance measured with DTPA. However, a better correlation is seen
for the renovascular hypertension and the renal dysplasia or hypoplasia
groups (P < 0.001). We can suggest a score by noninvasive procedures
to predict proximal lesions (thrombosis or stenosis > 50%) of the renal
artery using hypertension severity, the rate of peripheral plasma renin
activity, kidney area ratio, and the ratio of separated kidney 6FR
evaluated by 99'" Tc DTPA. This technique is helpful for surgical
decision: Nephrectomy is only justified if the kidney GFR is lower than
10 to 15 ml/mn/1.73 m2. For greater values, the only decision is
revascularization, if possible, especially in the renovascular hyperten-
sion group.
Significance of mesangial 1gM deposits in nephrotic syndrome. A.
Gonzdlo, F. Mampaso, N. Gallego, L. Orofino, R. Matesanz, and J.
Ortuño. Servicio de NefrologIa, Centro Ramón y Cajal, Madrid, Spain.
We have studied 19 patients, ages ranging from 3 to 45 years, with
idiopathic nephrotic syndrome. Eight patients were male and Il female.
On light microscopy, mild to moderate increase in cells and mesangial
matrix were observed. By immunofluorescence, generalized and diffuse
deposits of 1gM, with or without C3, in the glomeruli were demonstrat-
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ed in all patients. Electron microscopy showed electron dense deposits
in the mesangium in 16 patients. At the time of biopsy, serum 1gM was
significantly raised (P < 0.01). Two patients experienced spontaneous
remission and the remaining 17 were treated with prednisone. Twelve
patients were steroid-responsive and five were steroid-resistant. Only
one of the five steroid-resistant patients treated with chiorambucil
showed response. We compared the course of these patients with those
of 11 patients presenting idiopathic nephrotic syndrome without immu-
nofluorescent deposits, aged 3 to 59 years, who received the same
therapy. One patient experienced spontaneous remission, eight patients
were steroid-responsive and two steroid-resistant. Mean follow-up was
3 years for the two groups. With regard to the response to therapy, no
distinction could be drawn between the two groups in the early
response to steroid treatment. In summary, the presence of 1gM
deposits in idiopathic nephrotic syndrome is not a marker for the early
response.
Genetic hypertension of the donor and blood pressure of the recipient of
a cadaver kidney graft. E. Guidi, V. Dallosta, E. Rivolia, A. Vazzola
and G. Bianchi. Divisioni di Nefrologia e Dialisi Ospedale Niguarda e
Ospedale Policlinico; e Instituto di Clinica Medica I e Scuola di
Specializzazione in Nefrologia Medica, Universitd degli Studi di Mi/a-
no, Milano, Italy. In two strains of genetically hypertensive rats (MHS
and DS), the role of the kidney in determining the level of the blood
pressure (BP) after kidney cross transplantation has been established.
The present study conducted on kidney-grafted patients selected from
the transplantations performed in Milan from 1969 to 1980 was per-
formed to determine if the presence of hypertension in the donor family
affects the BP of the recipient through the grafted kidney. The donors'
and recipients' families were interviewed and the BP of the parents and
of all the other relatives who collaborated was measured after 5 mm of
rest while sitting. We selected 50 recipients out of 42 donors who were
comparable for age, sex, body weight, body surface, duration of
hemodialysis (HD) before grafting, BP, and antihypertensive therapy
(AHT) during the last month of HD. These patients had equal preva-
lence of hypertension in their families, almost equal prevalence of the
types of kidney disease and they were rather equally distributed among
the four units where they were grafted and followed thereafter. Twenty-
seven of these patients received a kidney from a donor whose parents
were normotensive (diastolic BP < 90 mm Hg: normotensive donor
patients NDP), while 23 received a kidney from a donor with at least
one parent hypertensive (diastolic BP 95 mm Hg or on AHT:
hypertensive donor patients HDP). These patients were followed for 2
years and their data were collected retrospectively from the clinical
charts. After the transplantation, we observed no differences between
NDP and HDP with respect to: number of acute rejections, plasma
creatinine, doses of prednisone and prevalence of alternate day therapy
and diastolic BP during the entire period of follow-up. Systolic BP and
AHT scored arbitrarily were significantly different (P < 0.01) during the
first 4-month period and during the second year. These results support
the hypothesis that the kidney, through a genetically transmitted
mechanism, can affect the BP independently from innervation when
transplanted.
Evidence for transient macrophage Fe receptor blockade and glomeru-
lar infiltration during Plasmodium yoeli infection in two strains of mice. J.
S. Hunt, C. H. Dechenne, J. B. Foidart, and P. Mahieu, Departments
of Medicine and Pathology, State University of Liege, Liege, Belgium.
CBA and C57 BI mice were injected intraperitoneally with 5.l0 red
blood cells parasitized with Plasmodium yoeli obtained from infected
mice of the same strain. The Fc-receptor function of the reticulo-
endothelial system was sequentially measured in vivo and in vitro by:
(1) determination with gamma camera and ex vivo counting of the
spleen/liver uptake ratios 40 mm after intravenous injection of 99Tc-
labelled, heat-damaged, isologous red blood cells; (2) calculation of
percentage peritoneal or spleen macrophages "rosetting" IgG-coated
erythrocytes. Results showed: (I) an Fe-receptor blockade which
appeared in both strains of mice on day 4 of infection, and progressively
disappeared after day 30 in CBA and after day 40 in C57 BI mice; (2)
this blockade coincided with maximum levels of parasitemia, serum-
specific antibodies and circulating immune complexes; (3) glomerular
mesangial Ig and C3 deposits observed by immunofluorescent micros-
copy in both strains of mice 6 to 40 days after infection; (4) at this time,
morphological studies of kidney sections showed an endocapillary
proliferation and an increase in mesangial matrix which was noticeably
more pronounced in C57 Bl mice; (5) mouse glomerular cultures
demonstrated increased numbers of macrophages and increased out-
growth capacity of intrinsic glomerular cells between days 6 and 8. This
data showed that a transient Fe-receptor blockade occurred in both
strains of mice infected with Plasmodium yoeli and was associated with
a glomerular infiltration by macrophages. However, the severity and
duration of Fe-receptor blockade and subsequent renal involvement
appeared increased in C57 BI mice, suggesting some differences in the
efficacy of immune complex clearance between the two strains of mice
in this model.
Dissociation of calcium and magnesium tubular handling in stone
formers. M. Labeeuw, N. Pozet, C. Gerbaulet, P. Zech, and J.
Traeger. Chalon-sur-Saone and Lyon, France. A decreased urinary
magnesium/calcium ratio (Mg/Ca) was previously reported in stone-
forming patients (SF). The normal relationship between fasting urinary
Mg and Ca excretion (expressed as Mg/Cr and Ca/Cr) was first
established in 31 male controls (C): Mg/Cr = 0. 1072 + 0.2747 Ca/Cr, r =
0.6197). Relative hypomagnesiuria (HoMg) defined as Mg/Cr too low (<
—2 SD) for the observed Ca/Cr value, was recorded in 21(37.5%) out of
56 male, normocalcemic SF, with normal renal function (Cl. Cr = 119
17 ml/min). When comparing HoMg SF to other SF, no difference was
observed for age, body weight, Ccr, blood values of Mg, Ca, P, Na, K,
pH, osmolality, urinary excretion rates of P, Na, K, NH4, H, urinary
pH, and flow rate, tubular reabsorption rates (TR) of Na and P. HoMg
SF exhibited significantly lower Mg/Cr and higher TR Mg (P < 0.005)
than C and other SF. In HoMg SF Ca/Cr was higher and TR Ca lower (P
< 0.025), but when urinary AMPc excretion was considered, the
frequency of SF with renal hypercalciuria was not significantly different
in the two groups. HypoMg SF showed urinary oxalate excretion rates
not different from C but lower than other SF (P < 0.005), and lower
blood uric acid value (318 31 SM/liter, P < 0.025), with an
insignificantly different urinary excretion rate, suggesting a higher uric
acid clearance. Thus, we found in 37.5% of 56 SF a dissociation of Mg
and Ca urinary excretion and tubular reabsorption rates with relative
hypomagnesiuria, which is not associated with any other striking
abnormality of the studied parameters, suggesting an extrarenal phe-
nomenon. This abnormality might be of pathophysiological importance
in normo-oxaluric SF.
Tests with SQ 14225 in transfemoral renal angioplasty. S. Lamperi, U.
Benizzelli, and S. Carozzi. Division of Nephrology, St. Martin Hospi-
tal, Genoa, Italy. Results obtained in renal angioplasty with SQ 14225
tests in five patients with renovascular hypertension are reported in this
research. In the same subjects, arterious nephrography, radionephro-
gram, evaluation of RAS activity both in basal conditions and under
inhibition tests, dosage of urinary sodium and kallikrein concentration
have been performed. Results indicate that in all patients there occurred
an initial noticeable arterial fall; this decrease remained more or less
steady according to the major or minor initial positivity of the inhibition
test. In subjects showing a clear positivity of the lateralization test,
arterial pressure fall was about 50% and remained subsequently steady
at about 20 to 30%; in subjects showing a moderate positivity of the
lateralization test, less marked results have been obtained. The data
show the importance of these tests either for selection or prognosis in
patients proposed for this kind of treatment.
Outcome of Berger disease in children. M. Levy, S. Gonzales, M.
Broyer, and R. Habib. Department of Pediatric Nephrology, Institut
National de Ia Sante et de la Recherche Medicale, et U.192, Hôpital
Necker, Paris, France. The clinical course and outcome of 92 children
with Berger disease, less than 15 years of age at onset and followed for
at least 1 year have been retrospectively analyzed. A good correlation
was found between the glomerular lesions observed by light microscopy
(LM) and the outcome. By LM, five groups were identified: minimal
glomerular changes (MGC), 26; focal and segmental glomerulonephritis
(FSGN), 42; pure proliferative glomerulonephritis (PPGN), 3; prolifera-
tive glomerulonephritis (PGN) with crescents (focal, 20; diffuse; 1).
Most patients with MGC, FSGN, and PPGN had, at the last observa-
tion a microscopic hematuria and/or a mild proteinuria (the proteinuria
is, however, over 1 g/day in eight patients with FSGN). None of them
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has an impairment of renal function but four with FSGN have devel-
oped hypertension. Eleven patients (5 MCGN, 1 PPGN, and 5 FSGN)
have remained in clinical remission for several years, but mesangial IgA
deposits were still present in the only patient who had a repeat biopsy
while in remission. By contrast, none of the patients with PGN and
focal crescents has had a prolonged remission. Five patients developed
terminal renal failure (TRF) 0.11, 2.2, 4, 7.9, and 10 years after onset.
Two additional patients were in moderate chronic renal failure (CRF)
with hypertension 10 and 12 years after onset. The other children show
a persistent nephropathy, the proteinuria being over 1 glday in five and
three developed hypertension. Lastly, the patient with PGN and diffuse
crescents was in TRF 9 months after onset. Although the clinical course
is benign in children with MGC, FSGN, and PPGN, most patients show
a persistent nephropathy. A few patients are in prolonged clinical
remission, but the disappearance of IgA deposits has not, to our
knowledge, been reported. Progression to CRF or TRF is possible in
children with PGN and crescents. Therapeutic trials using drugs with
side effects should therefore be used only in this group of patients.
Abdominal echography and surveillance of long-term peritoneum effi-
ciency in CAPD. A. Limido, L. So! biati, P. Cantu, and A. Giangrande.
Renal Unit, General Provincial Hospital, Busto Arsizio, italy. CAPD
survival rate showed a reduction of 20 and 40%, respectively, at the first
and second years. While early failures were related to complications of
the catheter or of its implantation, late ones were mainly due to the loss
of dialytic efficiency of the peritoneal membrane. We therefore evaluat-
ed urea, creatinine, and phosphate long-dwell equilibration curves (DI
P), and the mean daily ultrafiltration rate (UF) in 12 patients undergoing
CAPD from I to 27 months (mean, 8.83). These data were related to
abdominal echographic studies evaluating the thickness of parietal
peritoneum and dialysate inflow and outflow dynamics. All patients had
and maintained D/P ratios in the normal range. Three patients (in CAPD
since 27, 27, and 18 months) had a significant reduction of UF, with
positive fluid balance even with the use of hypertonic solutions. This
caused the transfer of one patient to hemodialysis. Echography demon-
strated abdominal fluid collections at the end of the drainage in four
patients. Parietal peritoneum thickness was significantly correlated
with the time of treatment. Our results suggest that loss of UF efficiency
may be an early complication of CAPD which can make the therapy
clinically inadequate. Echography proved to be useful in investigating
the abdominal cavity.
Is sieving coefficient during sodium convective transport strictly related
to the Donnan effect? F. Locatelli, R. Ponti, L. Pedrini, R. Costanzo,
and S. Di Filippo. Divisione di Nefrologia e Dialisi, Ospedale di Lecco,
Italy. The aim of this study is to verify if the sieving coefficient during
convective transport of sodium is related to the Donnan effect. Forty-
six isolated ultrafiltrations were performed: 30 in 23 patients using
cuprophan membranes (A) and 16 in 12 patients using cellulose hydrate
membranes (B). Moreover 21 "in vitro" isolated ultrafiltrations were
performed with cellulose hydrate membranes (C) using blood with
different total protein concentrations, at blood flows varying from 100
to 300 mI/mm and transmembrane pressures varying from 100 to 400
mm Hg. Changes in plasma water sodium concentration during the
passage through the dialyzer as well as the differences between ultrafil-
trate sodium (NaUF) and plasma water sodium were evaluated. The
sieving coefficient (SC) was calculated as 2 NaUF/NaI+NaO, where
Nat and NaO are the sodium concentrations in plasma water at the inlet
and the outlet of the dialyzer. Results are shown in the table below.
NaT NaO NaUF SC TPI
A 144.21 4.23 144.90 4.35 140.02 4.09a0.969 0.009 6.78 0.75
B 150.22 3.71 151.02 3.86a 141.97 3.33a0.943 0.010 7.28 0.76
C161.45 0.81 162.53 0.83 158.93 0.69a0.98l 0.0055.08 1.63
With cellulose hydrate a significant correlation was found between SC
and TPI (r =
—0.65, P < 0.01 in B; r = —0.64, P < 0.005 in C). The
difference in sieving coefficient between B and C seems to be due to the
different protein concentrations, as the correlations between SC and
TPI suggest. These results support the hypothesis that sodium sieving
coefficient during convective transport is related strictly to the Donnan
effect. The lack of significant correlation between SC and TPI with
cuprophan suggests a determinant role of membrane permeability. The
trend of SC values to decrease with decreasing blood flow and
increasing transmembrane pressure suggests the role of other factors
such as blood flow, transmembrane pressure, and hematocrit, which
must be further investigated.
Removal of various hormones by hemofiltration (HF) and plasma
changes in chronic treated patients. J. Luno, E. Olivas, M. Resano, S.
G. de Vinuesa, G. Barril, C. Gonzalez, S. Alonso, N. Lopez, and F.
Valderrabano. Servicio de Nefrologia y Seccion de Radioimmunoana/i-
sis, Hospital Provincial, Madrid, Spain. Hemofiltration is performed by
convective transport through membranes with a cut-off for solutes with
a molecular weight of 20,000 daltons, and all biological substances with
a molecular weight below the membrane cut-off may be lost in the
ultrafiltrate. To evaluate the importance of this loss in causing hormonal
depletion syndromes, we measured different hormones by radio-
immunoassay in six chronic uremic patients treated by periodic HF. We
also compared plasma hormone levels between the beginning and the
end of the study period in HF (6 to 16 months, mean II months). We
found in the ultrafiltrate detectable levels of growth hormone (GH)
cortisone (C), gonadotropins (FSH, LH), parathyroid hormone (PTH),
and gastnne (G). The loss of GH was associated to a decrease in
posthemofiltration plasma values. Plasma C concentration also de-
creased at the end of each HF session, although this fact may be
explained by the circadian rhythm of C. The ultrafiltrate concentrations
of prolactin, T3,T4,TSH, and testosterone were low or undetectable.
This hormonal loss across the membrane did not account for significant
variations in plasma concentrations at the end of the follow-up period
of: C (16 5 vs. 18 3 sg/dl), GH (3.3 1.6 vs. 4 2 ng/ml), FSH (18
13 vs. 16 11 mU/mi), and LH(52 34 vs. 57 31 mU/mi). G
plasma levels did not change in the two patients who could be studied at
the end of the period. PTH values increased significantly with time on
HF (16.7 vs. 25 mU/mI) despite a large amount of this hormone detected
in the ultrafiltrate. This increase of PTH during HF is associated to a
decrease in plasma calcium concentration and may be related to a
negative calcium balance in HF compared with hemodialysis. Changes
in plasma concentration hormone levels makes interpretation of these
results difficult. Nevertheless, our data suggest that long-term HF does
not induce hormone depletion syndromes, probably due to increased
glandular secretory capacity.
Long-term plasma exchange in immunologically mediated glomerular
diseases. E. Lusvarghi, L. Furci, G. Malmusi, A. M. Savazzi, L.
Vandelli, E. Baldini, and P. Galli. Nephrology Unit and immunohae-
matology Service, University of Modena, Modena, Italy. Chronic
treatment with plasma exchange (PE) improved renal function in two
cases of immunological rapidly progressive glomerulonephritis, unre-
sponsive to intensive treatment with PE, corticoids, and immunosup-
pressive drugs. The first case (Wegener's granulomatosis) underwent
PE treatment for two periods of 20 and 44 weeks, respectively; renal
function recovered and persisted (plasma creatinine decreased from 4 to
1.4 mg/dl and then from 5 to 2.4 mg/dl). The second case (mixed
essential cryoglobulinemia IgG, 1gM) underwent regular dialysis treat-
ment after prolonged corticotherapy; PE alone was carried out for 74
weeks, and renal function recovered after the first 12 weeks of
treatment; plasma creatinine decreased and stabilized at 3 mg/dl. In
both cases improvement in GFR began after a period ranging from 4 to
12 weeks.
Uremic hypofibrinolysis as an increased risk for vascular access
survival. G. Mangiarotti, A. Thea, A. Pacitti, G. Squiccimarro, M.
Salomone, andA. Vercellone. Cattedra di Nefrologia Medica Dell'Uni-
versita' di Torino, Ospedale Maggiore S. Giovanni Battista, Torino,
Italy. In addition to a hemorrhagic diathesis in uremia, a thrombotic
tendency occurs, principally substained by a marked fibrinolytic system
impairment. Studies on fibrinolytic pathway by whole blood clot diluted
with phosphate buffer (Fearnley) and acetate buffer (Gallimore), Eu-
globulin lysis time and area, kallikrein and prekallikrein (chromogenic
P < 0.001 in comparison with NaT. Abbreviation: TPI, total protein
concentration in the blood at the inlet of the dialyzer, in g/dl; Nal, NaO,
NaUF in mEq/liter
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substrates), plasminogen, a2 macroglobulin, a1 antitripsin, c1 inactiva-
tor, inter a trypsin levels (radial immunodiffusion) show a significant
fibnnolytic activity decrease, for which an accumulation of inhibitors is
presumably the first responsible. These probably belong to the class of
small molecules abnormally retained in uremia, because hemodialysis
offers the best method of correction, mainly by an improved elimination
of these inhibitors (60 patients studied). On the contrary, hemofiltration
and particularly intermittent peritoneal dialysis are much less effective,
this latter probably because protein loss across the peritoneum is also
responsible for a loss of fibrinolytic activators, as in the nephrotic
syndrome. Hypofibrinolysis can induce an increased vascular risk, in
which repeated episodes of vascular access obstruction are also includ-
ed. In our patients a marked fall of fibrinolytic activators is associated
frequently with repeated vascular access thrombosis, surely demon-
strating a responsibility together with marked hypotension and compro-
mised vascular situation. Local introduction of fibrinolytic activators
(Urokinasi 100.000 to 200.000 U) rapidly declotted eight obstructed
vascular accesses (six carotids) since the dose was greater (400.000 U
24 hr) in patients with a more marked fibrinolytic impairment. We are
still trying to achieve chronic fibrinolytic activation by means of oral
Stanazolol (5 mg/day) whose capacity to induce fibrinolytic activation
has been demonstrated in diseases other than uremia.
Physko-chemical studies of urine environment by an improved comput-
ermodel system. M. Marangella, P. G. Daniele, M. Bruno, M. Ronzani,
S. Sonego, and F. Linari. Ospedale Mauriziano Umberto I and 1st.
Analisi Chimica Strumentale deli' Universitd, Torino, Italy. An accu-
rate estimation of urine saturation has an important role in the study of
calcium urolithiasis. Two approaches have been so far proposed: so-
called "ab initio calculation" by Robertson and Finlayson and the semi-
empirical method by Pak. Both have been criticized. Recently, we
proposed an improved computer model system by which the experi-
mental redetermination of the stability constant values at 37°C and at
the actual ionic strength of urine, allowed expression of the saturation
levels as free concentration product ratio (FCPR): ratio between the
calculated free ion product and the solubility product determined at the
same ionic strength and temperature conditions. Preliminary results of
measurements performed by our method and by Robertson's and Pak's
evidenced significant differences. So we re-examined some physico-
chemical aspects of calcium urolithiasis by applying our method to the
study of stone-formers. FCPR with CaOx H2O (whewhellite, WW) and
with CaHPO4 2H20 (brushite, BSH) have been assessed both in basal
conditions and after various forms of therapy in 130 patients. FCPR
with WW were significantly increased in the stone-formers as compared
to 40 healthy controls. The increases were independent of urine volume
and only poorly related to calcium and oxalate excretions. However,
hypercalciuric and hyperoxaluric patients showed higher degrees of
supersaturation. No difference has been found in FCPR values with
respect to BSH between controls and stone-formers. FCPR was corre-
lated weakly to pH and urinary Ca values. The effect of long-term
allopurinol and thiazide therapy did not significantly differ from that of
low calcium-oxalate diets.
Kallikrein activity (KA) in the rabbit microdissected nephron. Local-
ization to the granular distal parts. Effect of deoxycorticosterone (DOC)
administration. J. Marchetti, M. Imbert-Teboul, J. Aliegrini, and F.
Ahienc-Gelas. Laboratoire de Physiologie Celiulaire, College de
France, Paris, France. Kallikrein is synthesized in the kidney and
secreted into urine. It is well documented that urinary KA is increased
by mineralocorticoids and altered during hypertension. Specific KA has
not as yet been localized along a single nephron or quantitatively
studied. Glomeruli and tubular segments (0.4 to 2 mm in length) were
microdissected from collagenase-treated rabbit kidneys and solubilized
with 0.5% deoxycholic acid. KA on dog kininogen was measured in 450
tubular segments taken from ten rabbits using a sensitive radio-
immunoassay for kinins. Nearly all KA was found in the granular
portions of the distal (DCTg) and cortical collecting tubules (CCTg),
that is, the connecting tubule, as defined by embryologists. It averaged
1.956 0.196 pg BK/mm/mm of tubule in DCTg (N = 38) and 2.004
0.249 in CCTg (N = 19). KA was low in the thin descending limb (0.078
0.015, N = 18), the early bright distal tubule (0.114 0.027, N = 27)
and in the cortical (0.119 0.035, N = 24) and medullary (0.115
0.028, N = 18) collecting tubules. It was not detected in the other
segments or in the glomeruli. DOC treatment (5 mg/day, 12 days) did
not change KA in any segment but the connecting tubule; in DCTg, KA
was 6.302 1.079 in four DOC-treated rabbits versus 2.843 0.765 in
paired controls (P < 0.05). When KA was referred to as micrograms of
total proteins (instead of millimeters of tubule), the increase was no
longer significant (12.231 3.121 vs. 16.472 2.835). This suggests that
the DOC-induced increase in KA might be due, at least in part, to an
overall effect on protein synthesis.
Study of adequate conditions for the use of urinary cAMP as an index of
parathyroid function in hypercalciuric patients. M. E. Martinez, J. L.
Miguel, M. Salinas, P. Gomez, F. Mateos, A. Montero, andL. Sanchez
Sicilia. Servicio de Nefrologia, Servicio de Bioquimica, C. S. La Paz,
Madrid, Spain. To assess parathyroid function, the values of seric PTH
and cAMP in urine were studied in 17 normal subjects (N) and 104
hypercalciuric patients. Among the hypercalciuric patients 56 had
normal PTH values (group 1); 48 who had high levels of PTH were
termed normocalcemic (group 2A) and 15 hypercalcemic (group 211).
cAMP was measured in 24-hr urine samples after a low calcium diet as
well as in 2-hr urine samples after subsequent fasting. The results were
expressed in nmoles/dl of glomerular filtrate. Urinary cAMP excretion
shows a fair correlation with blood PTH levels, both when measured in
restricted diet and in 2-hr urine samples. Group 1 shows normal values
of cAMP in 24 and 2-hr samples, and group 2B higher rates in both.
However, there is an overlapping (60%) between the hyperparathyroid
and normocalcemic patients (group 2A) and N in the 24-hr urine
samples. This overlap is only 17% in 2-hr samples. We conclude that the
determination of cAMP in 2-hr urine samples after fasting and a
previous low calcium diet is a good index of parathyroid function.
Ambulatory evaluation of idiopathic hypercalciuria (IH). Results in 112
hypercalciuric patients. M. E. Martinez, J. L. Miguel, M. Salinas, P.
Gomez, A. Rodriguez-Carmona, F. Mateos, A. Montero, and L.
Sanchez Sicilia. Servicio de Nefrologia-Servicio de Bioquimica, C. S.
La Paz, Madrid, Spain. We studied 112 patients with nephrolithiasis
and normocalcemic hypercalciuria following an ambulatory protocol;
considering hypercalciuria to exist when calcium (Ca) was higher than 4
mg/kg body weight/24 hr on a daily intake of 800 to 1000 rug Ca. We
measured in a Ca-restricted diet (400 mg/day) 24 hr urine sample Ca,
phosphorus (F), hydroxiproline (Hp), and cAMP; while the patients
were on this diet, a fasting 2 hr urine sample was collected after an
overnight fast and venous blood was obtained to evaluate Ca, P, PTH,
alkaline phosphatase, and urinary cAMP. Thirty-six patients were
found to have renal hypercalciuria(RH); 31 had high values of PTH and
cAMP, and in five patients one of these values was increased. Patients
with RH had lower values of Tm P than normal subjects, and 29 RH
presented high values of Hp. Two of them showed hypercalcemia after
treatment with thyazide diuretics, with surgical confirmation of para-
thyroid adenoma and hyperplasia. Sixty-nine patients had normal
values of PTH and cAMP. Patients with increased urinary calcium in a
restricted sample were classified as absorptive hypercalciuria (AH)
type I, patients with low urinary Ca in a restricted sample, as AH type
II, and patients with low Tm P as renal leak of P. Seven patients could
not be included.
Therapeutic plasmapheresis: Study of 41 patients. J. M. Mauri, R.
Poveda, M. T. Gonzalez, E. Andres, J. M. Grino, R. Romero, A. M.
Castelao, A. Caralps, J. Andujar, J. Alsina, J. A. Rodriguez, and L.
Piera. Ciudad Sanitaria PrIncipes de España," Hospitalet de LI,
Ciudad Sanitaria Valle de Hebrón," Barcelona, Spain. Plasmaphere-
sis alone or associated with steroids and cytostatics has become widely
used, mainly due to its unusually good results in cases where classical
treatments fail. Clinical and technical observations in 41 patients and
373 plasma exchanges have been recorded.
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Im-
Diagnosis N
Clinical
data
prove-
ment
Fail-
ure
Rejection 10 RF 2 (1 tr) 8
TMA 5 ARF 1 4(Id)
RPGN:
AGBMA 2 ARF 0 2(ld)
Primitive 5 RF 4 I
Vasculitis 4 RF 4 (1 tr) 0
MCGN.I idiop. 4 4 NS, 3 RF 4 0
MEC 2 NS 2 0
SLE 4 3 NS, 2 RF 1 3 (1 d)
Plasmocytoma 2 ARF I I
Weil disease I ARF 1 0
Guillain.B. 1 — 1 0
Gibencl. intox. 1 — 1 0
All patients were kept under steroid and cytostatic associated treat-
ment. Clinical and biological changes were unrelated to the method,
plasma separation, or plasma filtration, used. Thrombosis of the
subclavian access, the most used, was reduced greatly when antiplate-
let aggregating agents were added to the treatment. Our results suggest
a potential relationship with the kind of renal lesion, extent of sclerosis
and severity of the functional impairment.
Hypocomplementemic urticarial vasculitis with glomerulopathy and
renal venulitis. A. Meyrier, P. Francais, M. Grandmougin, P. Ronco,
P. Lesavre, B. Mougeno, L. Morel-Maroger, and C. Francais.
Nephrology Unit, Hôpital lenon, Dermatology Unit, Hôpital Saint-
Louis, Nephrology Unit, Hopital Necker, Paris, France. A 58-year-old
woman had been observed for over 3 years for atypical chronic
urticaria, arthralgias, and abdominal pain. Angioneurotic edema super-
vened. Proteinuria was discovered. She had an inflammatory syndrome
with leukoneutropenia and anti-leukocyte antibodies, low CH 50, Clq.
and C4 levels. There was no Cl esterase functional deficit. The search
for anti-Clq precipitins was negative. Lupus erythematosus was ruled
out (negative ANF, negative antisingle-stranded DNA antibodies, Farr
and Crithidia, negative soluble nuclear antigens). Skin biopsy speci-
mens disclosed leukocytoclastic angeitis. Immunofluorescence of skin
lesions showed strong fixation on the vessels with anti-IgM antiserum
and a continuous granular band along the dermoepidermic junction with
anti-IgG, 1gM, and C3 antisera. The same Ig's were detected in
unaffected, exposed, and unexposed skin areas. By light microscopy
renal biopsy disclosed mesangial thickening, thickened glomerular
capillary walls and large perivenular inflammatory infiltrates. Immuno-
fluorescence showed diffuse mesangial fixation of anti-IgG, anti-Clq,
anti-C4 antisera, and anti-C3 antisera. There was a strong, granular
anti-lgG antiserum fixation on TBM. With I mg/kg/day of prednisone
clinical manifestations and proteinuria disappeared. The chronic hypo-
complementemic urticaria with cutaneous vasculitis, angioneurotic
edema, glomerulopathy and renal venulitis that the patient had was not
due to systemic lupus. It is germane to McDuffie angeitis, and in this
setting, it is the 12th reported patient with documented renal involve-
ment. The mechanisms of hypocomplementemia and renal venulitis,
two original features of this unusual syndrome, are discussed.
Reciprocal outcome of chronic peritoneal dialysis and abdominal
surgery. M. G. Moutel, J. Paineau, C. Fontenaille, J. Guenel, and J.
Visset. Service de Médecine IV, Nephrologie, et Service de Chirurgie
Générale I, Hôpital Saint-Jacques, Nantes, France. The authors report
25 patients receiving chronic peritoneal dialysis (PD) who had abdomi-
nal surgery. Ten hernias or eventrations were treated either in emergen-
cy for occlusion (with postoperative complications in three patients,
one of whom died) or without emergency (with uneventful postopera-
tive recovery). Five omentectomies were performed allowing better
recovery of peritoneal dialysate in four patients. Five laparotomies
were carried out for abdominal emergencies not related to PD and in
which clinical diagnosis was overt, while surgical exploration was done
in five patients of long-lasting peritonitis with severe clinical symptoms
(fever, abdominal retention, occlusive syndrome) but without any
localized signs. No pathological process was found in any patient.
Peritonitis improved only after the Tenckhoff catheter was removed.
Therefore, the following procedure is proposed: (I) Each hernia or
eventration, pre-existing or secondary to peritoneal catheter implanta-
tion, must be treated by surgery as early as possible, and PD must be
carried out in short cycles. (2) In case of abdominal complication of PD,
surgical treatment is useful only if clinical signs are unequivocal. Long-
lasting or recurring peritonitis without localized signs does not require
surgery but only stopping PD for a long time.
Urea kinetics and dietary protein intake in hemofiltration. A. Pacitti,
D. Boggio-Bertinet, G. Mangiarotti, R. Cardelli, C. Canavese, G. P.
Segoloni, F. Baizola, and A. Vercellone. Cattedra di Nefrologia
Medica dell' Universitd di Torino, Ospedale S. Giovanni Battisra,
Torino Servizio di Dietologia, Ospedale S. Giovanni Battista, Servizio
di Dialisi, Ospedale Maggiore di Chieri, Chieri, Italy. Parallel assess-
ments of nitrogen balance, daily dietary protein intake (DPI), and urea
nitrogen generation (Ge) were made in seven stable patients undergoing
postdilutional hemofiltration (HF): DPI and protein catabolic rate
(PCR) very closely correlated with G. By this correlation, from G
calculation it has been possible to evaluate PCR-DPI status in patients
on: (I) standard efficiency HF (seven patients) versus high efficiency
HF schedule; (2) different buffer content in reinfusate solution (seven
patients on lactate = 35 mEq/liter solution vs. seven patients on lactate
= 42 mEq/liter solution). The PCR-DPI values in patients on standard
HF and lower buffer solution are in the lower normal range and lower
than values from patients on high efficiency HF or higher buffer
solution-standard efficiency HF. In conclusion, PCR-DPI seems to
correlate with urea kinetics, but other factors (acid-base balance) must
also be taken into account.
Hemofiltration treatment (HF) in the management of diabetic uremic
patients (DUP). A. Pacitti, G. Triolo, M. Salomone, G. P. Segoloni, G.
Civati, C. Guastoni, A. Perego, and A. Vercellone. Cattedra di Nefrolo-
gia Medica dell'Universitd di Torino, Ospedale S. Giovanni Battista,
Torino, Divisione di Nefrologia and Dialisi, Ospedale Niguarda "Ca
Granda", Milano, Italy. The increasing number of DUP accepted on
RDT in the last years may be the most difficult and frustrating burden in
the management of high risk uremic patients and requires research into
more adequate ways of treatment for these clinically complex patients.
An HF protocol was followed on six DUP for a 10.6 month/patient
period. In every patient, good intratreatment pressure stability was
recorded; in the patients who were on hemodialysis (HD), a significant
decrease of hypotension, vomiting, cramps, headache, and intertreat-
ment weight gain was observed. Ocular bleeding episodes were not
noted, there were no changes in visus and fundus status before or after
HF. In the longest follow-up patient (18 months) the fluoroangiogram
did not show before or after HF modifications. Intratreatment insulin
curves were compared with insulin ultrafiltrate losses. A decreased
daily insulin requirement was recorded in the patients who were on HD.
Use of lactate as a buffer did not create problems of acid-base
correction. Compared to 15 DUP on CAPD treatment for 101 months,
the HF patients showed complications and a lower hospitalization rate
(1.32 vs. 3.14 days/treatment month). In conclusion, an integrated
CAPD-HF-transplant program seems to suit DUP best: HF permits
going on when the CAPD fails, for example, in those CAPD patients
with ultrafiltration problems obliged to use high hypertonic solutions.
Urine sediment in glomerular hematurias. Comparative study with
kidney biopsy findings. H. Pellet, C. Donne, P. Deteix, S. Colon, and P.
Zech. Laboratoire d'Histologie, U. E. R. Grange-Blanche, Clinique
Nephrologique Hopital F. Herriot, Lyon, France. The glomerular or
nonglomerular origin of red blood cells (RBC) in urine sediment (US)
can be established by observing their morphological features with phase
contrast microscopy. This technique also allows the identification of
hematic (H), hematico-hyaline (HH), granular (G), and granulohyaline
(GH) casts (C), and of lipids (L). This study includes 67 patients who
had a kidney biopsy to investigate hematuria and/or proteinuria and
whose US contains "glomerular" RBC. Eighty-two percent of the US
contain other elements: HC 15%, HHC 29.8%, GC and/or GHC 62.7%.
Anatomical lesions are found in all patients. In nine patients they are
exclusively vascular and the US does not show GC or GHC. In the 58
other patients, glomerular changes are found; 91% of the patients show
other elements besides the RBC: HC and/or HHC 49.2%, GC and/or
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GHC 74%, L 3%. Among these, there are 39 intercapillary glomerulone-
phritis, [30 with IgA deposits (7 HC, 10 HHC, 19 GC and/or GHC, 5
isolated RBC), 4 with 1gM deposits (1 HHC, 4 HCG), 5 with undeter-
mined deposits], 5 extramembranous glomerulonephritis (2 HC, 1
HHC, 4 GC and/or GHC, I L), 3 focal segmental hyalinosis (2 GC and/
or GHC, I isolated RBC), 2 mesangioproliferative glornerulonephritis (2
GC and/or GHC, I L), 2 amyloidosis (2 HHC, 2 GC and/or GHC), 5
endocapillary proliferative glomerulonephritis (2 HC, I HHC, 5 GH
and/or GHC), and 2 glomerulosclerosis (2 GHC, 1 L). In all these
patients a close correlation is observed between the extent of the US
findings and renal lesions. In conclusion, when US shows "glomerular"
RBC, we always find renal lesions. If the lesions are exclusively
vascular, the US does not contain GC or GHC, in glomerulonephritis
casts are often associated with hematuria. A correlation is observed
between the intensity of the US anomalies and of the renal lesions, but
there is no correlation between US and the histological type of
glomerulonephntis.
Continuous ambulatory peritoneal dialysis (CAPD), ultimate treatment
of congestive cardiomyopathy with moderate renal failure (RF). K.
Rebaiz, R. Thiernesse, and C. Wolf. Hôpital Manchester, Charleville
Mézières, Groupe Medical St. Rémy, Reims, France. A man, aged 54,
was hospitalized for chronic heart failure. He had exhibited severe
hypertension for 15 years. Treatment, comprising digoxin (125 mg a
week), furosemide (500 mg per day), prasozin (15 mg per day),
dihydralazine (75 mg per day), with restriction of sodium and fluid did
not reduce sodium-water retention. Mental disturbances, hypertension
(160/110mm Hg), oliguria, RF (serum creatinine 442 moles/liter) were
noted. Radionuclide angiocardiography and echocardiography indicat-
ed congestive cardiomyopathy based on the following parameters:
blood volume (BV) = 4.7 liters, cardiac output (CO) = 3.2 liters/mm,
ejection fraction (EF) = 0.45, mean circumferencial fiber shortening
velocity (VCF) = 0.8 c/s. Medical treatment failed to control the
situation, and CAPD was performed with 2-liter bag exchanges per day.
Dialysis solutions were available at concentrations of 15 g/liter and 42.5
g/liter. CAPD obtained 8 kg hydrosodic depletion, blood pressure
normalization and improvement of mental status within a few days. A
cardiologic check-up was performed after 6 months: BY = 3.3 liters,
CO = 2.9 liters/mm, EF = 0.46, VCF: 0.8 c/s. Good results were
maintained 9 months. The patient was then changed to iterative
peritonitis, followed by hemofiltration. Death occurred 3 months later
due to cerebrovascular accident. CAPD can thus be ultimate treatment
of refractory cardiac edema associated with moderate renal failure.
Continuous ambulatory peritoneal dialysis in insulin-dependent diabet-
ic patients: a 40-month experience. J. Rottembourg, Y. el Shahat, A.
Agrafiotis, Y. Thuillier, F. de Groc, C. Jacobs, andM. Legrain. Service
de Nephrologie et Laboratoire de Biochimie, Groupe Hospitalier Pitie-
Salpetriere, Paris, France. From August 1978 to December 1981, 24
insulin-dependent diabetic patients (IDD) with endstage renal disease
(ESRD) have been treated by continuous ambulatory peritoneal dialysis
(CAPD). The average time on CAPD was 10.6 months (range 2 to 32
month). At 1 year the actuarial survival rate was 84% and the rate of
continuation on ambulatory peritoneal dialysis was 75%. We observed
six deaths and three transfers to hemodialysis. The incidence of
peritonitis (1 episode per 12.2 patient/months) was lower than that in
our nondiabetic patient population. Insulin was introduced into the
peritoneal cavity through the catheter. Mean residual renal creatinine
clearance, around 3 mI/mm, and mean peritoneal creatinine clearance,
and around 4 mI/mm, remained stable during the period of observation.
The daily use of no more than 2 liters of dialysate with 4.5% dextrose
may prevent major serum lipid abnormalities. Hypertension was con-
trolled easily in most patients but postural hypotension was also
observed. Stabilization or improvement of retinopathy was observed in
12 out of 15 patients followed for at least 6 months. IDD patients should
be offered all modes of replacement therapy, within an integrated
program of treatment of ESRD. For some of them CAPD may be the
best alternative.
Magnesium excretion in idiopathic hypercalciuria (IH). Difference
between absorptive (AH) and renal hypercalciuria (RH). M. Salinas, P.
Gomez, J. L. Miguel, M. E. Martinez, E. Herrero, A. Montero, and L.
Sanchez Sicilia. Servicio de Nefrologia-Servicio de Bioquimica. C. S.
La Paz, Madrid, Spain. We observed magnesium (Mg) excretion
obtained from 66 patients with IH: 36 with AH and 30 with RH versus
21 normal subjects (N). All of them were evaluated while on a free diet,
54 after a diet restricted in calcium (400 mg/day) and Mg (100 mg/day)
for 5 days and 49 subjects after a subsequent fasting. The urinary
excretion of Mg expressed as mg/kg body weight (mg/kg) and fractional
excretion of Mg (FEMg) were determined as shown in the below table.
Free diet Restricted diet Fasting
FEMgmg/kg FEMg mg/kg FEMg
N 1.35 0.49 2.8 1.1 1.19 0.28 2.7 1.0 2.1 1.1
AH 1.78 0.50a 3.5 l.l 1.39 0.52 3.0 1.2 2.6 1.6
RH 1.97 0.77 4.2 l.8a 1.63 0.62b 3.7 l.2 3.2 1.Sb
P < 0.01
P < 0.05 vs. normal subjects.
Mg excretion during random diet was increased significantly in HA and
HR versus N. During restricted diet and subsequent fasting, Mg
excretion was increased significantly in HR. These results suggest that
Mg reabsorption is impaired in HR, which may be primary or secondary
to altered renal handling.
Report 1981: Group for multicentric study of CAPD in Italy. Clinical-
organizative evaluation in 450 patients of 21 sample centers. G. P.
Segoloni, Divisione di Nefrologia e Dialisi, Ospedale S. Giovanni,
Torino, Italy. The AA reports the results of the second Italian CAPD
registry dealing with 450 patients from 21 Italian sample centers
(January 1980 to February 2, 1982). Detailed data were obtained from
computerized analysis of 450 items according to the BMDP system. The
AA briefly summarizes the purposes of the analysis: (1) importance of
performing CAPD as an adjunctive substitute treatment within pre-
existing systems. The AA considers the organization of the Centers and
the role assumed by CAPD with regard to the overall pool (stock data)
and to new patients beginning substitutive treatment in 1980 (January to
June) and 1981 (flow-data); (2) indications for CAPD in new patients
(mean age, occupation, previous treatment, renal disease, high risk,
selection criteria). On the basis of the reported data, CAPD is indicated
in 56% of high risk patients (mean age, 55) (3) schedule of treatment
(technical and methodological aspects); (4) actuarial survival curves
(evaluation of overall pool, drop-outs, and survival of patients stopping
CAPD). Particularly the AA stress the utilization of other modes of
substitute treatment; (5) incidence of peritonitis: evaluation of bacterio-
logical and clinical aspects and indications for terminating treatment; (6)
54 clinical-laboratory data recorded after 6, 12, and 24 months; (7)
incidence of complications, causes of interruption and death are also
reported. The AA stress the increasing importance assumed by CAPD,
which actually represents a mode of treatment for 28% in the overall
pool of new admissions in sample centers. Nevertheless, the AA think
that CAPD patients must be considered as a group whose clinical profile
is not definitive; so an alternative mode of treatment must be taken into
account.
IgA membranoproliferative glomerulonephritis (MPGN) in patients
with alcoholic liver cirrhosis. A morphologic study. A. Sessa, G. Fer-
rarjo, P. Palazzi, L. Torri-Tarelli, D. Corti, and L. Brevi. Ospedale di
Vimercate, Istituto di Anal omia Normale, Scuola di Specializzazione in
Nefrologia, Università di Milano, Italy. Patients with alcoholic liver
cirrhosis show polyclonal immunoglobulin elevation, predominantly of
IgA. The high levels of serum immunoglobulins could result from
antibody formation directed against antigens originating in the gastroin-
testinal tract and from liver impairment in the selective removal of
polymeric IgA from serum into bile. The predominant role of polymeric
IgA in producing histological lesions of the glomerular tufts is well
known. Elevated levels of polymeric IgA are observed in the serum of
patients with IgA nephropathy such as Berger disease, Henoch-Schon-
lein purpura or alcoholic cirrhosis. We performed renal biopsies in
seven proteinuric patients with alcoholic cirrhosis of the liver. Light
microscopy showed MPGN in all the patients. Mesangial and suben-
dothelial granular deposits of IgA, often with C3, were evident in all
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glomeruli observed. Electron microscopy showed some peculiar fea-
tures: (1) subendothelial basement-membrane-like material along the
glomerular capillary walls and mesangial, subendothelial, and intra-
membranous electron-dense deposits; (2) round areas of rarefaction,
500 to 1000 A in diameter, characterized a "moth-eaten" feature of
some glomerular walls; (3) glomerular mesangial cells showed alter-
ations of mitochondria. These morphologic findings may be useful to
differentiate: (I) the MPGN of cirrhotic patients from idiopathic
MPGN; (2) the IgA glomerulonephritis of alcoholic cirrhosis from other
IgA nephropathies (Berger, Henoch-Schonlein). The granular IgA
deposits, often with C3, and the electron-dense deposits, both mesan-
gial and panetal at the glomerular site, suggest a pathogenetic role of
circulating immunocomplexes.
Treatment suggested by the short and medium term biochemical effects
of parathyroidectomy (PTX). S. Sforzini, M. R. Vigano, and B. Re-
dae!li. Divisione di Nefrologia e Dialisi, Ospedale di Monza, Monza,
Italy. Parathyroidectomy was performed in 15 patients undergoing
dialysis. The post-PTX follow-up was divided into two periods: (1)
"hypocalcemic period" until the minimum level of calcemia was
reached (average 8.8 days) and (2) "hypercalcemic period" until the
peak of calcemia was reached (average 167 days). During the first
period total Ca, iP decreased significantly (P <0.001 for all); pH
and plasma bicarbonate increased significantly (P < 0.01 and P < 0.001,
respectively). Each of these parameters correlated with all the others.
The Ca/iP ratio was found to be nearly constant at 1.5 during the first
period. During the second period alkaline phosphatase correlates
negatively with time (P < 0.001) and a significant correlation was found
between the time of peak hypercalcemia and dihydrotachisterol (DHT3)
dose/kg/day (P < 0.001). In conclusion, the data from the hypocalcemic
period suggest that the disappearance of Ca and iP from the extracellu-
lar fluids (ECP) is due to the formation of the initial solid phase of the
bone mineralization as underlined by the constant Ca/iP ratio of
disappearance (Rasmussen and Bordier). The administration of calcium
does not influence the follow-up data; whereas the administration of
1.25 vitamin D3 or other metabolites with the same action is suggested
to prevent the danger due to the sudden unavailability of the interacellu-
lar buffers for the extracellular acid-base balance because of the sudden
lack of PTH. The correlation between the time of appearance of
hypercalcemia and the dose/kg/day of vitamin D suggests that it should
be possible to calculate the maintenance dose of vitamin D.
Clinical features and long-term course of non-A, non-B hepatitis in
patients and staff in a hemodialysis center. N. Simon. Centre Pasteur-
Vallery-Radot, Paris, France. Between August 1977 and May 1982,
prophylaxis against hepatitis carried out through twice-monthly routine
assessments of serum transaminases in hemodialysis patients led to the
detection of non-A, non-B hepatitis in 29 out of 129 patients (22.5%)
hemodialyzed for at least 6 months and in six out of 69 staff members
(8.6%) working in the Center during the same period. Diagnosis of non-
A, non-B hepatitis was based upon: (I) rise of ALT levels; (2) lack of
evidence of toxic hepatitis; (3) lack of evidence of recent serological
infection with hepatitis B, hepatitis A, or Herpes viruses. Of the 35
hepatitis patients only 24 were followed up for at least 1 year (19
patients and 5 staff members) and were included in this study. During
the initial phase of hepatitis, 11 out of 24 subjects (45%) complained of
asthenia; mean maximum rates of serum AST were 180 U 110 (upper
normal range < 40) and mean maximum rates of serum ALT were 325 U
200 (upper normal range <40). In four patients (21%) and three staff
members, serum ALT returned to normal values within an average of 2
months (I to 4 months); in the 15 other patients (79%) serum ALT
returned to normal values within an average of 18 months (8 to 42
months); in two staff members, serum ALT remains elevated for 16 and
24 months. In conclusion, (I) non-A, non-B hepatitis affected about one
out of five patients and one out of 12 staff members followed up in the
dialysis Center for at least 6 months; (2) non-A, non-B hepatitis is
asymptomatic in half of the patients and anicteric in all cases; (3) no sign
of hepatocellular damage was recorded in any subject; (4) in four out of
five patients and in one out of three staff members, non-A, non-B
hepatitis lasted for more than 6 months; (5) however, all hemodialysis
patients recovered within an average period of 1 .5 years and a maxi-
mum interval of 42 months.
Minimum prevalence and evolution of IgA nephropathy in a French
region with 250,000 inhabitants: seven year follow-up. P. Simon, M. P.
Ramée, K. S. Ang, B. Genetet, and R. Fauchet. Nephrology Unit, La
Beauchée Hospital, Saint-B rieuc, and Pathology Laboratory and Tis-
sue Typing Laboratory, University of Medical School, Rennes, France.
Between April 1, 1975, and April 1, 1982, a single nephrology unit
recruited patients with renal disease in a district with 250,000 inhabit-
ants. One hundred ninety-two biopsy specimens corresponded to
primary glomerulonephritis. Of these 192 specimens, 58 showed diffuse
mesangial deposition of IgA (30.2%) and therefore were classified as
IgA nephropathy. Each patient was born and lived in the district.
During the considered period, minimum prevalence of IgA nephropathy
was evaluated as two cases per every 10,000. Forty-four were men
(76%). At the time of biopsy, mean age was 35 16 years for men and
38 17 years for women. Twenty-two patients had recurrent macro-
scopic hematuria (38%) at presentation. The other patients showed
microscopic hematuria, asymptomatic proteinuria, or both. Symptoms
were noted during a physical examination at military induction in 15
patients (25.8%) and at work in 19 (32.7%). The duration of symptoms
before biopsy averaged 4.5 4.1 years. HLA-Bw35 was found in 27.3%
of the patients versus 12.9% of the controls (NS). HLA-DR4 was found
in 41.6% versus 19.5% (x2 = 7.95, P < 0.01). During a mean evolution
of 6.12 6.85 years, renal failure occurred in nine patients (15.5%),
terminal uremia in three (5.1%) who entered hemodialysis. Among
those 12 patients (nine men and three women), seven developed
transient nephrotic syndrome and 11 severe hypertension. At the time
of biopsy, nine had nonspecific vascular lesions, and 11 severe tubu-
lointerstitial lesions. HLA-Bw35 antigen was seen in only one patient
and HLA-DR4 in two patients. This study shows the frequency of IgA
nephropathy in a French region and defines evolution and prognosis of
the disease.
Prostacyclin consumption in hemolytic uremic syndrome (HUS), dis-
seminated intravascular coagulation (DIC), systemic lupus erythematosus(SLE) and in the spontaneous abortive pathology of pregnancy. P.
Stratta, C. Canavese, G. Segoloni, G. Camussi, F. Bussolino, and A.
Vercellone. Cattedra di Nefrologia Medica dell' Universitd di Torino,
Ospedale Maggiore S. Giovanni Battista, Torino, Italy. We have
studied plasma stimulating and serum inhibiting factors to prostacyclin
(P0!2) generation with biological (incubation with rat aorta and aggre-
gometric evaluation) and radioimmunological (6 Keto PGF1-RIA test)
methods in three patients with HUS, three with CID, three SLE, and
two pregnant women without renal damage, hospitalized because
profound piastrinopenia was detected. As previously reported, in our
three HUS stimulating factors to P012 also decreased. Surprisingly, in
three patients in which laboratory data showed a classical pattern for
DIC (fibrinogen < 100 mg%, Antithrombin III <70%, FDP < 40 igIml,
QUICK and PTT lengthened) stimulating factors to POT2 also de-
creased. All patients were treated with plasma infusion (P1) (70 ml/kg/
day and Dipirydamol (10 mg/kg/day), except one with plasma exchange
(PE). Three patients with HUS (one post-infection, one eclampsia, one
post-partum) in anuric acute renal failure (ARF) had improved renal
function (50% level) after 1, 10 and 18 months. Of three patients with
DIC (one crush-syndrome, two eclampsia), all anuric ARF, two had
improved renal function after 1 and 10 months, one died anuric at the
25th day septicemia. Serum inhibitors were detected only in two SLE,
one without renal impairment, one with ARF, treated with PE, in which
renal function rose to the 50% level after I month. In two pregnant
(month 4) women, the profound piastrinopenia was not accompanied by
other hematological abnormalities except for a marked haptoglobin
consumption and schistocytes in blood smear. Plasma factor stimulat-
ing PG!2 were decreased and returned to normal range after spontane-
ous abortion which occurred in both 2 weeks after the hospitalization.
We conclude that a PGI2 activator fall is not only specific for HUS but
can take place also in CID. Except for SLE, P1 and not PE is necessary
because no inhibitors have been demonstrated. Furthermore, selective
platelet aggregation with P012 consumption can be responsible for
spontaneous abortive pathology of the pregnancy, and haptoglobin and
schistocytes may be useful early markers of this syndrome.
Activation of the coagulation and tibrinolytic pathways and vascular
damage: Are they progression factors in Berger GN? P. Stratta, M.
Dogliani, M. Messina, B. Malfi, and A. Vercellone. Caitedra di
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Nefrologia Medica dell'Universitd di Torino, Ospedale Maggiore S. G.
Battista, Torino, Italy. Berger GN was diagnosed in 92 patients with
normal renal function by percutaneous renal biopsy. Among these, 41
were followed from 0.5 to 9 years. In 6 (14.5%) slight renal failure
(serum creatinine  1.5 mg/dl) occurred after 3.5 years (mean), and
dialysis was undertaken in four others (10%) after 4 years (mean). All
patients were studied by the following parameters: plasma and urine
PF4, and betathromboglobulin (BTG), thromboxane B2 (TXB2)(RIA-
test), kallikrein and prekallikrein (chromogenic substrates), plasmino-
gen, antithrombin III, a2 macroglobulin, a1 antitrypsin, Cl inactivator,
inter atrypsin (all radial immunodiffusion), FDP (latex test). The
presence of schistocytes was checked on blood smears. By light
microscopy, renal specimens were examined for signs of vascular
injury. By direct immunofluorescence, anti-platelet and -fibrinogen
antisera were used on 4- thick cryostat sections. Plasma and urine
platelet endogranular constituents were not increased significantly
either in comparison with 40 normal subjects or between the two groups
of patients with and without functional impairment. The same held true
for the other parameters studied. None of the patients studied showed
platelet deposits by IF, whereas fibringen was detected with equal
frequency in two of the patients. By light microscopy, vascular damage
was overt in 100% of those with slowly progressing renal failure, in 25%
of those dialyzed and in 32% of those without renal impairment. Our
study may rule out the activation of the coagulation and fibrinolytic
pathways as a significant progression factor in the natural history of
Berger GN. Signs of vascular damage and hypertension may mean a
slow progression of the disease with features superimposable on those
of benign nephroangiosclerosis, which is generally favorably affected
by hypotensive treatment but do not seem the preeminent feature of
those forms which rapidly progress to severe renal failure.
Urinary cAMP excretion (cAMPE) and serum PTH assessment in
primary hyperparathyroidism (HP) and in recurrent calcium nephrolith-
iasis (RCN). M. Surian, F. Malberti, G. Colussi, G. Pentoriero, G.
Rombold, P. Cosci, A. Aroldi, E. Lorenzano, G. Graziani, and L.
Minetti. Renal Unit, E. 0. Niguarda, Policlinico di Milano and
Ospedale Maggiore di Lodi, Lodi, Italy. In 145 RCN and in 20
surgically proven HP, cAMPE (kit Amersham) and serum PTH levels
(kit Sorin) were measured on I g and low Ca diet (< 400 mg/day).
Normocalcemic RCN patients were divided into normocalciuric (NC, N
= 64) and hypercalciuric (IH): calciuria (UCaV) on I g Ca diet was
greater than 280 9 and> 320 mg/day (A + 2 SD in 17 women and 10
men, normals = N). After 10 days of low Ca diet IH were further
divided into "absorptive" (AH), (N = 62) when UCaV normalized on a
low Ca diet and into "renal" (RH, N = 20) when UCaV remained
higher than 265 9 and 303 d mg/day (A + 2 SD on low Ca diet in N).
cAMPE was greater than 4.5 nmoles/dl GFR (A + 2 SD in N) in 70% of
HP, and it distinguished this group (cAMPE = 6.3 2.76 and 6.3 3.2
on I g and low Ca diet, respectively) from N (2.5 0.7 and 2.42 1.04,
P < 0.001) and from the other groups; however, cAMPE did not
discriminate among NC (2.43 1; 2.75 1.42), RH (3.07 1.86; 2.85
0.86), All (2.95 1.3; 2.4 I) and N. cAMPE was greater than 4.5 in 6
out of 20 RH and in 10 out of 62 AH. PTH levels were greater than 5.1
lU/mi (A + 2 SD in N) in 89% of HP and distinguished these patients (8.3
4.9) from the others; PTH levels in RH (5.05 1.5) and in All (3.9
1.8) were higher than in N (2.9 1.1, P < 0.01 and P < 0.001,
respectively) and in NC (3.3 0.9, P < 0.05 and P < 0.005); PTH did
not discriminate between All and RH. In conclusion; (1) PTH and
cAMPE are useful parameters in the diagnosis of primary hyperpara-
thyroidism; the combined diagnostic sensitivty of both the tests is 95%
(19 out of 20 patients). (2) No relationship was found between PTH and
cAMPE and the type of hypercalciuria; elevated cAMPE and PTH
values may be found in All and RH. The evaluation of parathyroid
activity in idiopathic hypercalciuria remains a problem open to specula-
tion; its clinical usefulness seems to be unreliable.
Single needle plasmapheresis. R. Vanholder, M. de Clippele, and S.
Ringoir. Renal Division, University Hospital, De Pintelaan, Gent,
Belgium. Until now single needle plasmapheresis using one vascular
accesss has only been possible with the centifugal technique. In our
renal division, however, unipuncture membrane plasmapheresis is
currently performed, using our conventional unipuncture pressure-
pressure hemodialysis equipment with alternating blood flow pattern
and hollow fiber plasma separators. We have so far performed 64
plasmapheresis sessions in eight patients (four with rapidly progressive
glomerulonephritis and four with metastatized cancer). A 16-gauge
single lumen needle introduced into a peripheral vein, or a subclavian
vein hemodialysis catheter, was used as a vascular access. Blood flows
of 150 mI/mm were used. Mean transmembrane pressures built up in
the blood compartment were 56 7 mm Hg. Average plasma volumes
extracted per Session were 3262 50 ml over a time period of 110 5
mm (30.71 1.33 mI/mm). Protein extraction ratios per plasmapheresis
session were: A IgG: —52%, AlgA: —55%, A 1gM: —53%, A C3: —49%.
A good therapeutical response was obtained. It is concluded that single
needle membrane plasmapheresis can be performed using conventional
unipuncture hemodialysis equipment and that the performance is ade-
quate. Besides the economic advantages, only one vascular access is
needed.
Renin release in patients with IgA mesangial deposit glomerulonephri-
tis. A. Zuccald, C. Chiarini, E. Degli Esposti, R. Gaggi, A. Santoro, A.
Sturani, and P. Zucchelli. Department of Nephrology and Dialysis,
Malpighi Hospital, Bologna, Italy. The authors studied plasma renin
activity (PRA), plasma aldosterone (PA), plasma noradrenaline (NA),
and exchangeable sodium (ES) in 32 patients (including both normoten-
sive and hypertensive patients) with biopsy-proven IgA mesangial
deposit glomerulonephritis. All patients had normal renal function
(plasma creatinine <1.5 mg/dl). The average PRA and PA revealed in
the normotensive patients was found to be higher than in the hyperten-
sive patients and the control subjects. Seven of the normotensive
patients were defined as having a high renin level. In these patients the
renal biopsy showed modest segmental and focal proliferation without
either glomerular sclerosis or vascular damage. No relation was found
between the levels of PRA and either NA or ES. PRA in these patients
was inhibited using either a beta-blocker (propranolol 0.15 mg/kg i.v.),
or a cyclooxygenase inhibitor (indomethacin 150 mg/day orally for 3
days). The beta-blocker was found to inhibit the release of renin almost
completely, while the inhibitory effect of indomethacin was only partial.
The increased level of renin release in normotensive patients with IgA
mesangial deposit glomerulonephritis seems to be related to increased
intrarenal sympathetic activity which is not revealed by the level of
plasma catecholamines.
Biopterin metabolism in chronic uremia. J. L. Dhondt, C. Noel, M.
Dracon, P. Vanhille, and A. Tacquet. Inst it ut Pasteur de Lille, Service
de Nephrologie, Hôpital Calmette, Lille et Service DHemodialyse,
Centre Hospitalier de Valenciennes, Valenciennes, France. Phenylata-
nine-, tyrosine-, and tryptophan-hydroxylases required tetrahydrobiop-
term (THB) as cofactor. Biopterin, the reduced form of THB, and
neopterin, an intermediate in the synthesis of THB, have been mea-
sured in serum and urine of chronic uremic patients by means of a
HPLC method. In uremic patients, neopterin (N) and biopterin (B)
levels in serum were significantly increased when compared to control
values. In addition, raised N/B ratio (x5.4) were observed. These
results were not only explained by the reduced GFR; the N/B changes
rather suggested an impairment of THB metabolism. The present
findings are consistent with the hypothesis of a decreased activity of
dihydropteridine-reductase (DHPR) which maintains biopterin in its
active tetrahydrogenated form. DHPR has been described recently to
be sensitive to many endogenous and exogenous factors (for example,
aluminum). Consequently, a reduced pool of cellular THB could be
expected and explain the abnormalities in aromatic aminoacids metabo-
lism, cathecholamine synthesis, and some of the neurological distur-
bances which have been reported in chronic uremic patients.
Randomized immunogenicity trial of three hepatitis B vaccination
protocols in uremic patients treated by chronic hemodialysis. P. Jun gers,
A. M. Courouce, E. Benhamou, A. Laplanche, F. Degos, J. Brangier,
and J. Crosnier. Centre National de Transfusion Sanguine, institut
Gustave Roussy, Institut Pasteur Production and Department of
Nephrology, Necker Hospital, Paris, France. In a previous study we
showed poor immune response in chronic hemodialysis patients who
received hepatitis B vaccine. We prospectively compared immunoge-
nicity of the standard protocol P1 (three subcutaneous injections of I ml
Abstracts
Institut Pasteur Production vaccine at monthly intervals) to two experi-
mental protocols P2 (three injections of 2 ml) and P3 (three injections of
1 ml plus a fourth 2 months later). From March to August 1981, 215
chronic dialysis patients (123 males, 92 females), aged 50.1 14.6
years, treated in 13 hepatitis free centers (175 patients) or at home (40
patients) with negative serology for HBsAg, anti-HBs and anti-HBc
were assigned randomly to protocols P1(70 patients), P2 (69 patients) or
P3 (76 patients). Of them, 203 completed the vaccine protocol and 15
were lost for follow-up after the last injection. Plasma samples taken
before and 2, 4, 6, 9, and 12 months following the first injection were
titrated simultaneously for anti-HBs using radioimmunoassay. The
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percentage of responders (defined by anti-HBs titer 10 mIU/ml in at
least two successive samples) was significantly higher with protocols P2
(75 5.5%) and P3 (69 5.5%) than with P1(46 6%, P < 0.001) but
did not significantly differ between P2 and P3. In the 129 responders
geometric mean of anti-HBs titers measured at month 6 was 60, 192,
and 268 mIU/ml for P1, P2, and P3, respectively. We conclude that
response rate and anti-HBs antibody titer may be significantly im-
proved in chronic hemodialysis patients by means of reinforced vacci-
nation protocols but still do not reach the response levels observed in
healthy subjects. This suggests the need to study the response to
vaccine in uremic patients prior to endstage renal failure.
